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Abstract 
Among the intestinal tumours of hematopoietic origin, lymphoma is the most common in 
the dog The multicentric lymphoma is more common than the intestinal form, while the 
.alimentary lymphoma usually accounts for 7% of all canine lymphomas and 5-7% of all 
gastrointestinal neoplasms. Recent studies have shown that canine intestinal lympho-
mas are to great extent of T-cell origin.  Affected dogs most often present with a recent 
history of non-specific signs, like vomiting, diarrhea, anorexia and lethargy. The dogs 
involved are most commonly adult or old subjects, with an average age of 6,7 years. 
The most commonly involved breeds are Boxer, Shar-Pei and Golden Retriever. In light 
of the clinical and symptomatic overlap between IBD and enteropathy-type lymphoma, 
patients are often submitted to endoscopic examination. The endoscopic examination of 
the small bowel in the lymphoma group showed an aspect referred by gastroenterolo-
gists as “clobbedstone appearance” of the intestinal mucosa: the submucosal edema 
and the ulcerative disease with crisscrossing of the ulcers creates a pattern character-
ised by multiple, similarly-sized rounded densities that rise above a flattened plane, 
which has been likened to roads paved by multiple similarly-sized 'cobbled' stones. In 
dogs with this endoscopic aspect, the cytological examination alone has shown in our 
study a good diagnostic accuracy in the differential diagnosis between lymphoma and 
IBD. In fact, we argue that a cytological examination of squash-prep samples is a valu-
able method for the detection of a infiltrating enteropahy. In our study, we evaluated the 
samples using an interpretative algorithm based on a reduced number of some selected 
cytomorphological clues. These criteria were: 1) presence of lymphoid blast cells, 2) fine 
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structural change of the lymphoid blasts’s membrane, 3) presence of lympho-glandular 
bodies.  
The most outstanding result, was the higher diagnostic accuracy of squash-prep cytolo-
gy compared with endoscopic biopsy histology. Histopathology and immunohistochem-
istry are generally considered useful in the differential diagnosis between IBD and lym-
phoma. In our study however, although the evaluation of histopathologic results is not 
within the aims of the present work, the diagnostic performances of histopathology on 
endoscopic biopsies didn’t show a better accuracy better than those of cytology alone. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
 
The small intestine (SI) works as an interface between the external environment and the 
body, and is both an absorptive surface and a barrier; it must digest and absorb nutri-
ents while excluding antigens and microbes and eliminating fecal waste. 
The alimentary system varies in its architecture and function among animal species. Pet 
carnivores tend to develop alimentary neoplasia far more often than herbivores. This 
can be partially explained by their long life span and an exposure to environmental, 
cancerogenic  factors similar to those of humans beings. Various types of neoplasms 
occur in the gastrointestinal system of domestic animals. Intestinal neoplasms are diag-
nosed most frequently in dogs and cats.  
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1. ANATOMY AND PHYSIOLOGY 
 
Anatomical regions 
The SI can be likened to a convoluted tube, extending from the pylorus of the stomach 
to the ileo-colic valve. It exists a continuity with the external environment, proximally 
from the oral cavity via the esophagus and stomach, and distally to the anus via the 
large intestine (Buddingtone RK, 1996; Kararli TT, 1995; Snipes RL and  Snipes H, 
1997). 
1.1 Duodenum 
The first part of the SI, the duodenum, comprises about 10% of its total length. It ex-
tends dorsally from the pylorus and to the right, at the level of the 9th intercostal space, 
where is mantained in its position by the hepatoduodenal ligament. It turns then caudal-
ly into the descending duodenum  and again at the caudal flexure near the pelvic brim. 
It is in close association with the common bile duct and the head and right limb of the 
pancreas, which lie in its mesentery. 
The common bile duct and one pancreatic duct enter the duodenum via the major papil-
la. In dogs, an accessory pancreatic duct often enters at a minor papilla more distally 
and slightly more ventrally, but there is a range of variations in the actual number of 
ducts and their drainage pattern from the pancreas. The papillae are notable endoscop-
ic landmarks in dogs.  
The distal duodenal flexure, where the duodenum courses to the left side of abdomen is 
often at the limit of reach of a standard 1-meter gastroscope (except in small dogs). In 
dogs the anti-mesenteric side of the duodenum is marked by a line of whitish, mucosal 
depressions signifying the presence of specialized lymphoid areas, the Peyer patches. 
Secretory Brunner glands and annular mucosal folds are features of the human proxi-
mal duodenum, but are not present in dogs. After the distal duodenum flexure, the as-
cending limb of the duodenum crosses the midline and ends at the level of L6 close to 
the root of the mesentery near the left kidney, with a mesenteric attachment to the co-
lon, the duodeno-colic ligament. 
1.2 Jejunum 
The middle part of the SI, the jejunum, arises as an indistinct structural and functional 
transition from the duodenum and forms the majority of the SI. The jejunum is loosely 
suspended in the middle of the peritoneal cavity in a dorsal mesentery, forming mobile 
loops, and is potentially palpable throughout its length in cooperative and non-obese 
patients. The mesentery is normally a continuous sheet that is folded to allow the SI to 
loop within the peritoneal cavity, unlike in humans where segments of the duodenum 
(and colon) are retroperitoneal. The mesentery carries the vascular, lymphatic, and 
nervous connection between the SI and the rest of the body. 
Defects in the mesentery, most often traumatic in origin, can allow internal hernia for-
mation and small intestinal incarceration. An outpouching of the dorsal mesentery of the 
stomach forms the greater omentum. This structure functions as a protective, immuno-
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logic organ, having the ability to migrate to sites of intraperitoneal inflammation and po-
tentially prevents leakage from an intestinal perforation and seal off pockets of infection. 
1.3 Ileum 
 
The ileum constitutes approximately the final 30 cm of the SI. The transition from jeju-
num to ileum in humans is based on changes in diameter, color, and the presence of 
Peyer patches; in dogs the distinction has been arbitrarily based on the extent of at-
tachment of the ileocolic ligament. In fact, the basic structure of the ileum is not different 
from the rest of the SI and there’s no clear microscopical demarcation from the jejunum. 
However, the ileum does have in dogs some unique functional characteristics, such as 
the absorption of bile salts and cobalamin. It is also a site of dense lymphoid follicle ex-
pression. Merkel diverticulum, a remnant of the embryonic omphalo-mesenteric duct, 
found in the ileum of approximately 2% of people and a potential source of bleeding, 
obstruction, intussusception, and volvulus, is not reported in dogs. The ileum ends at 
the ileocolic valve in close association with the cecocolic junction. 
2. Blood Supply, Lymphatic Drainage,  innervation 
Blood supply to the proximal duodenum is provided by the celiac artery, whereas its 
anastomoses between its cranio-pancreatico-duodenal branch and caudo-pancraetico-
duodenal branch represent the major blood supply to the remainder of the SI and prox-
imal colon, anastomosing distally with the caudal mesenteric artery. The celiac artery 
forms an arcade along the mesenteric border of the jejunum and ileum, with a short an-
ti-mesenteric ileal branch. Its branching nature is an important consideration when as-
sessing the viability of lengths of SI during surgical resection and end-to-end anastomo-
sis. The venous drenage of the whole SI is ultimately to the liver via the epatic portal 
vein. There exist multiple embryonic vessels linking portal venous drainage and the sys-
temic venous system (i.e., via ovarian veins, caudal vena cava, and esophageal veins) 
but they only become a functional shunt as a consequence of chronic portal hyperten-
sion. Lacteals in the villi drain via intestinal lymphatics in the mesenteric lymph nodes 
and then in the cisterna chili and the thoracic duct. Vagal and sympathetic innervation 
coordinate with the intrinsic enteric nervous system and enteric hormones to regulate SI 
motility and function. 
3. Gut-associated Lymphoid Tissue 
The GI tract is the largest immunologic  organ in the body, and the SI comprises a large 
component of the mucosal immune system. Within the SI, the Peyers patches act as 
inductive sites and are covered with a specialized epithelium containing microfold (M) 
cells, which sample luminal antigens. Activated lymphocytes migrate via mesenteric 
lymph nodes to the circulation, from where they home to their effector sites, the lamina 
propria and epithelium. 
The GI immune system is compartmentalized into: 
a) afferent or inductive sites, where antigen-presenting cells (APCs) prime naïve T 
and B cells to initiate the immune response, either by processing and presenting 
local antigens or by migration from the lamina propria (LP), an important site of 
antigen sampling. 
12 
 
b) efferent or effector sites, where the antibody and T-cell-mediated response is 
mounted after extravasation, retention, and further differentiation of the lympho-
cytes. 
The afferent arm of the GI immune system comprises Peyer patches (PPs), isolated 
lymphoid follicles (ILFs), and mesenteric lymph nodes (MLNs), while the efferent 
arm comprises lymphocytes located in the lamina propria and epithelium; cryp-
topatches, loosely organized clusters of approximately 1000 cells located at the 
base of the intestinal crypts. 
The intestinal lamina propria contains plasma cells, T cells and putative DCs (El-
wood CM et al, 2006; German AJ et al, 1999). Plasma cells are predominantly IgA⁺ 
and are concentrated within the crypt regions in the small intestine and deep lamina 
propria in the colon; fewer of them are found within the villi and superficial lamina 
propria of the colon and there is a progressive decline in the density of IgA⁺ plasma 
cells from the duodenum to the ileum (German AJ et al,  1999; Vaerman JP and 
Heremans JF, 1969; ; Willard MD et al, 1981). By contrast, CD4⁺ and CD8⁺ T cells 
within the canine lamina propria are concentrated toward the tips of the villi, with no 
apparent differences in proximal to distal small intestinal distribution (German AJ et 
al, 1999; Elwood CM and Garden OA, 1999). The ratio of CD4⁺/ CD8⁺ T cells is ap-
proximately 60:40 in the lamina propria and 15:85 in the epithelium  (Elwood CM and 
Garden OA, 1999). Subtractive analysis suggests that a population of 
CD3⁺CD4⁻CD8⁻ cells exist in the canine villus epithelium, thought to represent  T 
cells. Immunohistochemical studies have suggested that αβ and  IELs are present 
in approximately equal numbers in the canine duodenum, jejunum, and ileum (Ger-
man AJ, et al, 1999). A significant number of lymphoid cells within the canine lamina 
propria are CD45R, raising speculation that a proportion of the T cells found within 
this compartment are naïve, in contrast with the predominantly effector/memory T-
cell phenotype observed in the human lamina propria (German AJ et al,  1999).s in 
the villus LP (Elwood CM and Garden OA, 1999; German AJ et al, 1998). However, 
the strongest MHC class II expression occur within the Peyer patches and some ex-
pression of this antigen is also apparent within the epithelium, particularly within the 
ileum (Elwood CM and Garden OA, 1999; German AJ et al, 1998). 
 
4. NON- NEOPLASTIC DISEASES OF GI TRACT: IBD 
 
 
Canine inflammatory bowel disease (IBD) is characterized by persistent gastrointestinal 
signs, histological evidence of mucosal inflammation, and general responsiveness to 
immunotherapeutic intervention (Strombeck DR, 1979). Clinical signs are highly varia-
ble, with disease severity resulting from numerous factors, including the presence or 
absence of active mucosal inflammation, organ(s) of involvement, physiological (e.g., 
anemia or vitamin deficiencies) consequences, and empirical therapies (Jergens AE  et 
al 1992; Guilford WG 1996; Jacobs G et al 1990; Jergens ,1999). 
Disease activity caused by IBD denotes the frequency and severity of clinical signs, 
such as vomiting and diarrhea, which occur as a consequence of diffuse mucosal in-
flammation. 
Assessment of IBD activity depends at present on a compendium of clinical, radiograph-
ic, endoscopic, and histological criteria that vary widely from one clinician to the other 
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(Jergens AE et al 1992; Guilford WG, 1996; Jacobs G et al 1990; Jergens,1999; Strom-
beck DR, 1979). The development of a standardized scoring index, such as those used 
in human IBD, would be useful in the management of affected animals, both as a 
measure of initial disease severity and to assess treatment responses (Jergens 
AE.,1999). 
 
4.1 Immunological and Inflammatory Mediators 
 
 
Recent advances in immunohistochemical techniques have identified imbalances in 
mucosal immune cells in canine IBD ( German AJ, 2001; Jergens AE et al, 1999; 
Jergens AE et al,  1996; Stonehewer J et al, 1998; Elwood CM and Garden OA. 1999; 
Locher C  et al, 2001; Jergens  AE et a,  2001). Immune-cell subset alterations involve 
both B and T lymphocyte populations and are broadly suggestive of pro-inflammatory 
changes within the mucosa, as compared to healthy dogs and dogs diagnosed with 
other causes of gastroenteritis. 
Some methods for evaluating canine IBD activity on the basis of nitric oxide production 
and altered mucosal cytokine messenger ribonucleic acid (RNA) expression have been 
described (Gunawardana SC et al, 1997; Jergens AE  et al, 1998; German AJ et al,  
2000;  Ridyard AE  et al,  2002; Fugiwara S et al,  2002;  Jergens AE et al, 2003).      
Furthermore, a strong association between serum CRP concentrations and a numerical 
canine IBD activity index (CIBDAI) has been noted (Jergens  AE et al, 2003). Prelimi-
nary data also suggest that perinuclear anti-neutrophil cytoplasmic antibodies might be 
useful as a serological marker of canine IBD (Allenspach K et al, 2003). To date, clinical 
research investigations (predominantly performed in the dog) validate disturbances in 
mucosal immunity in dogs with IBD. Unfortunately, only a few of these immunological 
parameters have been correlated to the severity of clinical disease activity. Morever, the 
lack of consistent endoscopic abnormalities and the absence of standardized histologi-
cal criteria for diagnosis of IBD hinder use of these indices as reliable markers of intes-
tinal inflammation. Recently, sonographic findings including focal bowel wall thickening, 
loss of an organized definition to the architecture of the intestinal wall, and mesenteric 
lymphadenopathy have been shown to be relevant in staging feline IBD (Baez JL et al  
1999). However, similar radiographic studies have not been performed in dogs with IBD. 
Given these limitations and previous experiences with human IBD indices, the use of 
gastrointestinal signs and simple parameters of inflammation (such as the acute-phase 
response) appear to be the best method of clinical assessment of canine IBD. Methods 
for evaluating canine IBD activity on the basis of nitric oxide production and altered mu-
cosal cytokine messenger ribonucleic acid (RNA) expression have been described [see 
Figure 1] (Gunawardana SC et al, 1997; Jergens AE et al, 1998;  German AJ et al,  
2000; Ridyard AE et al,  2002; Fugiwara S et al,  2002; Jergens AE et al, 2003). 
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Figure 1 JOURNAL of the American Animal Hospital Association. November/December 2004, Vol.40 
 
4.2 Simple Canine IBD Activity Index 
 
 
Recently, a prospective clinical study evaluating the use of a simple scoring index 
(CIBDAI) for assessment of canine IBD activity at diagnosis and following medical ther-
apy has been published. Using this system, six prominent gastrointestinal signs were 
scored 0 to 3 based upon the magnitude of their alterations from normal in a given IBD 
case. These scores were then summed, yielding a total cumulative CIBDAI score, which 
classified the disease as clinically insignificant, mild, moderate, or severe. The CIBDAI 
score was also correlated to the severity of histological lesions and the serum concen-
tration of CRP, an acute-phase reactant; these data showed that CRP levels were dra-
matically elevated in 58 IBD dogs at the time of diagnosis, particularly in those dogs 
(n=28) having CIBDAI scores reflective of moderate to severe IBD (Jergens AE  et al,  
2003). Additionally, both the CIBDAI score and the CRP concentration decreased in 
dogs following successful medical (e.g., immunosuppressive drug therapy and dietary 
management) therapy for their disease . 
It is noteworthy that dogs having diverse, non-IBD, enteric  (e.g., alimentary lymphoma, 
acute pancreatitis, mucosal histoplasmosis) and extra-alimentary tract disorders (e.g., 
multicentric lymphoma, inflammatory hepatic disease, severe cutaneous parasitism) al-
so had elevations of serum CRP. However, these elevations were significantly higher 
than the CRP concentrations found in IBD dogs, suggesting the presence of different 
acute-phase responses to severe localized inflammation in a variety of tissues. 
The accumulated observations derived from this investigation support the CIBDAI as a 
reliable measure of clinical signs of inflammation in dogs with IBD. 
It was also observed that both CIBDAI and CRP decreased in successfully treated 
dogs, making a measure of CRP level  suitable for laboratory evaluation of the effect of 
therapy in these patients. 
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5. NEOPLASTIC DISEASES OF GI TRACT 
 
5.1 Incidence and risk factors 
 
 
Reports vary, but overall intestinal tumors are rare in dogs and cats (Patnaik AK et al, 
1976). In a survey of insured dogs in the United Kingdom, a standardized incidence rate 
of  210/100,000 dogs was reported for alimentary tumors. This accounted for 8% of all 
tumor submissions (Dobson JM et al, 2002).  
Regarding specific tumor  types, lymphoma represents 6% of all canine tumors and is 
the most common intestinal tumor in most reports (Dorn CR et al, 1968; Crawshaw J, et 
al.,1998). Each tumor will be described in detail in the next chapter. Adenocarcinoma is 
the second most frequent tumor in both species, followed by mast cell tumors in cats 
and leiomyosarcomas or GISTs in dogs. 
As with many cancers, incidence of intestinal neoplasia increases in older dogs.  
Dogs are also usually middle aged or older, with mean ages most often between 6 and 
9 years, possibly older (12 years) for dogs with leiomyosarcoma  (Patnaik AK et al, 
1977; Couto CG et al, 1989; Kapatkin AS et al, 1992).  There is a slight sex predilection 
for male dogs to develop intestinal tumors in some studies. Some studies report a near 
equal incidence among male and female dogs (Miura et al, 2004; Myers NC and Pen-
ninck DG, 1994; Valerius et al, 1997),  although in one study 76% of dogs with intestinal 
adenocarcinoma were male (Paoloni et al, 2002). Males also appear overrepresented in 
smooth muscle tumors, comprising 82% of dogs with GI leiomyomas (Frost D et al, 
2003) and 76% of dogs with leiomyosarcoma. Additionally, 90% of dogs with GI lym-
phoma were male (Couto CG. et al, 1989).  
In dogs, few studies of intestinal neoplasia report an over-representation of specific 
breeds. Large breed dogs in general constituted most cases in a series of smooth mus-
cle tumors. Collies and German Shepherds are over-represented in some reports for 
intestinal tumors, especially adenocarcinoma and rectal carcinoma and polyps (Seiler 
RJ, 1979).  It is interesting to note, however, that in 104 benign and malignant tumors 
diagnosed in a cohort of military working dogs (German Shepherd dogs and Belgian 
Malinois), only one (a leiomyosarcoma) was intestinal (Peterson et al, 2000). Mast cell 
tumors have been reported primarily in Maltese, among other miniature breeds. Alt-
hough these reports came from Japan where small breeds are popular, over 50% of re-
ported cases in two series were in Maltese dogs, with a male predominance (Ozaki et 
al, 2002; Takahashi et al, 2000). 
Helicobacter pylori infection is associated with increased risk of gastric cancer in hu-
mans, although such association has not been confirmed in domestic animals. Multiple 
gastroduodenal adenocarcinomas and a rectal adenoma were found in a cougar with 
concurrent Helicobacter-like organisms and spirochetes. 
Finally, lymphoma (although not specifically intestinal) has been reported in a dog 4 
weeks after initiation of cyclosporine and ketoconazole therapy for anal furunculosis 
(Blackwood et al, 2004). An association between cyclosporine use in human transplant 
patients and the development of lymphoma is known. 
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5.2 Pathology and Natural Behavior 
 
 
Epithelial, mesenchymal, neuroendocrine, and discrete/round cell neoplasia can all be 
found in the intestinal tract. Most small intestinal neoplasia in dogs are malignant, 
whereas more distal areas of the GI tract tend to develop a more benign disease. 
Tumors include lymphoma, leiomyosarcoma and carcinoids. There are scattered case 
reports of uncommon tumors, such as extramedullary plasmacytoma, extraskeletal os-
teosarcoma, and hemangiosarcoma.  
 
5.2.1 Lymphoma 
 
 
Lymphoma is a common neoplasm in dogs and is anatomically classified into multicen-
tric, mediastinal, alimentary and extranodal form. The alimentary form is uncommon in 
dogs accounting for only 5% to 7% of all lymphomas (Couto et al, 1989; Theilen et al, 
1987).  The gastrointestinal  form of lymphoma is second in frequency only to the multi-
centric form (Theilen GH et al,1987). Despite gastrointestinal lymphoma being the most 
common extranodal form of lymphoma, the veterinary literature regarding the clinical 
outcomes of dogs afflicted with this disease is sparse. Much of the literature currently 
available on lymphoma in dogs is either centered on the multicentric form or does not 
distinguish between different anatomical forms (Kellen ET et al, 1993; Baskin CR et al, 
2009). As a consequence, direct interpretation of the information regarding the gastroin-
testinal form of lymphoma is exceedingly difficult. In fact, only one published case series 
directly examining clinical cases of canine gastrointestinal lymphoma has been pub-
lished, and results of chemotherapy were discouraging, with most dogs succumbing to 
the disease or being euthanized 3 to 14 weeks after diagnosis (Couto et al, 1989). 
 Currently, no clear consensus exists regarding sex predilection for lymphoma. In some 
studies, the percentage of males affected with gastrointestinal lymphoma was higher 
than that of females, while no difference found in other studies (Keller ET et al, 1993; 
Price GS et al, 1991).  Arguably, the low case number of these studies confere them a 
weak statistical power.  
The clinical presentation of these dogs may range from nonspecific signs such as ano-
rexia and lethargy to severe vomiting and hemorrhagic diarrhea (Couto CG et al, 1989; 
Ozaki K et al, 2006; Miura T et al, 2004).  It is generally  believed that full thickness bi-
opsy of the intestine is necessary to diagnose alimentary lymphoma as the lesion are 
usually deep-seated and invade the serosa.  A number of protocols is relatively suc-
cessfully used at the moment in the treatment of multicentric lymphoma (Keller ET et al, 
1993; Price GS et al, 1991; Halliwell B and Gutteridge JM. 1990). 
Reported median survival times range from 6 to 12 months, with complete remission 
achieved in 60% to 90% of cases (Vail DM et al, 1991). Canine gastrointestinal lym-
phoma has been treated empirically with many of these same protocols (Ozaki K et al, 
2006; Miura T et al, 2004). Couto and colleagues documented a poor clinical response 
to chemotherapy in dogs with gastrointestinal lymphoma, reporting that all but one dog 
died or was euthanized within 14 weeks after diagnosis (Couto CG. Et al, 1989). This 
poor outcome has been attributed to the use of single-agent therapy and the lack of 
good multi-agent protocols at the time of the study of Frank et al. (2007), hazard analy-
sis showed that dogs treated with multi-agent therapy had a death rate of 0.40.  This 
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rate was not significantly different from that of dogs treated with prednisone alone 
(P=0.074). Classification and diagnosis of canine lymphoma with regard mainly to GI 
lymphoma will be addressed in a separate chapter below. 
 
5.2.2 Epithelial Tumors 
 
 
The second most common intestinal tumors are those of epithelial origin. Colon and rec-
tum are the most common sites in dogs,  with rectum adenocarcinoma being more 
common than colon adenocarcinoma (Church et al, 1987). 
Histologic descriptors for carcinoma of the intestine include adeno- (forming glands), 
mucinous (>50% mucin), signet ring (>50% of cells have intracellular mucin), and undif-
ferentiated or solid (no evidence of gland formation). Grossly, colorectal adenocarcino-
mas may demonstrate a pedunculated (especially in the distal rectum), cobblestone 
(middle rectum), or annular (middle rectum) appearance, which may relate to behaviour 
and prognosis (Prater et al,2000). 
Carcinoids are rare tumors of neuroendocrine origin that have been infrequently report-
ed in dogs (Giles R. et al, 1974;  Patnaik AK et al, 1980; Albers TM et al, 1998; Sako T 
et al, 2003; Morrell CN et al, 2002) and tend to metastasize. In particular, in one study 
of canine intestinal neoplasms, it was shown that half of the metastases in the liver were 
from carcinoids, despite these tumors numbering only 4 out of a total of 35 (Patnaik AK 
and Hurvitz AI, 1980.). A similar aggressive pattern has been described in humans 
(Oberg K, 2001). Carcinoid cells arise from enterochromaffin cells of the intestinal mu-
cosa and contain secretory granules that may contain substances such as 5-
hydroxytryptamine (serotonin), secretin, somatostatin, and gastrin, among others (Head 
KW et al, 2002) . IHC for cytokeratin and for secretory substances such as serotonin 
may be positive, and serum concentration of serotonin has been documented at 10-fold 
the normal range in one dog with a carcinoid (Sako T et al, 2003). 
The prognosis for dogs with intestinal carcinoma or adenocarcinoma is considered poor, 
with survival ranging from 4 to 10 months (40% 1-year survival) when surgically treated 
(Crawshaw J et al, 1998; Paoloni MC et al, 2002; Birchard SJ et al, 1986). This poor 
survival rates are likely a result of a high metastatic rate. 40 to 50 percent of intestinal 
epithelial malignancies metastasize to local lymph nodes, while 30 to 40 percent metas-
tasize to distant sites (Patnaik AK et al,  1980; Crawshaw J et al, 1998; Kapatkin AS et 
al, 1992). The clinical importance of lymph nodal metastatic disease is further highlight-
ed by a report documenting a median survival time of dogs treated with surgery of 15 
months (67% survival at 1 year) compared with only 3 months (20% survival at 1 year) 
when lymph node metastases were present (Crawshaw J et al, 1998). 
 
5.2.3 Muscle Neoplasms 
 
 
The third most commonly reported intestinal neoplasm in dogs is of smooth muscle lin-
eage (leiomyoma and leiomyosarcoma). A more recently reported variant of leiomyo-
sarcoma and occasionally leiomyoma in dogs is the GI stromal tumor. 
Gastrointestinal stromal tumors (GISTs) are well documented in humans and have been 
also reported in dogs (Gillespie V. et al, 2011). These non-lymphoid tumors of mesen-
chymal origin were originally diagnosed as leiomyosarcomas, although some were 
leiomyomas. Histologically, GISTs are highly cellular mesenchymal tumors that do not 
show ultrastructural characteristics consistent with smooth muscle differentiation. GISTs 
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are thought to arise from multipotential stem cells phenotypically similar to interstitial 
cells of Cajal, driven by activating mutations in KIT gene. These cells regulate intestinal 
motility via an autonomic pacemaker effect. Although they can differentiate into smooth 
muscle cells if deprived of tyrosine-protein kinase Kit, GISTs are a discrete clinical entity 
from leiomyosarcoma (Miettinen M et al,  2002). GISTs are distinguished by high vi-
mentin immunoreactivity, low alpha smooth muscle actin reactivity, CD117 (Kit) reactivi-
ty, and a site predilection for the large intestine (compared to the stomach for leiomyo-
ma) (Frost D et al, 2003;  LaRock RG and Ginn PE, 1997). Activating mutations were 
identified in KIT exon 11 encoding the juxtamembrane domain in two of four cases ex-
amined (Frost D et al, 2003). CD117 reactivity is considered a major diagnostic criteria 
and in many studies is used to distinguish GISTs from leiomyosarcomas (Russell KN et 
al, 2007; Maas CPHJ et al, 2007).  When stratified as such, 28 of 42 leiomyosarcomas 
in dogs were reclassified as GISTs and only 2 of the 28 cases of GISTs (7%) gave rise 
to metastases. Investigators also found that GISTs were significantly more likely to oc-
cur in the large intestine, particularly the cecum, and leiomyosarcomas in the stomach 
and small intestine (Russell KN et al, 2007). 
Considering these findings, the incidence of true leiomyosarcoma is likely low because 
many previously reported cases may have actually been GISTs. Leiomyomas occur 
more commonly in the stomach but have also been reported in the esophagus, small 
intestine, and colorectum (Frost D et al, 2003). 
Extramedullary plasmacytoma (EMP) refers to solitary tumors with no evidence of sys-
temic multiple myeloma. Case reports of GI EMPs in dogs exist, though uncommon. In 
one study, a fourth of EMPs were found in the digestive system, particularly in the 
mouth (Platz SJ et al, 1999). One case report in a dog with EMP of the colon and rec-
tum was associated with monoclonal gammopathy (Trevor PB et al, 1993).  
Finally, one dog was diagnosed with ganglioneuroma of the rectum and experienced 
long-term survival following surgical resection (Reimer ME et al, 1999).  
When tumors of the GI system metastasize, sites of predilection in decreasing frequen-
cy include mesenteric lymph nodes (especially adenocarcinoma), liver (especially leio-
myosarcoma), mesentery, omentum, spleen, kidney, bone, peritoneum/carcinomatosis, 
and lung. Interestingly, metastases from intestinal adenocarcinoma were discovered in 
three dogs initially presented for testicular masses (Crawshaw J  et al, 1998;  Birchard 
SJ et al, 1986;  Cribb AE, 1988; Prater MR, 2000). One dog was presented for multiple 
cutaneous masses that suggested round-cell or epithelial malignancy on cytology, for 
which IHC confirmed an epithelial origin. A primary small intestinal adenocarcinoma with 
additional visceral metastasis was identified at necropsy (Juopperi TA et al, 2003). 
 
5.3 Cancer of the Gastrointestinal Tract:  Molecular Aspects 
 
 
With an increasing armamentarium of molecular diagnostics, insights into the patho-
genesis, progression, and prognosis of tumors are constantly emerging. Cellular adhe-
sion and invasion, such as tenascin-C- (Mukaratirwa S et al,2003;  Mukaratirwa S et al, 
2004), versican, hyaluronan (Mukaratirwa S et al, 2004), β-catenin, and e-cadherin-  
(McEntee MF and Brenneman KA, 1999; Restucci B et al, 2009; Aresu L et al, 2010), 
stromal development and progression of intestinal neoplasia, all play a role in the path-
ogenesis. The importance of the relationship between a tumor cell and its stroma should 
not be overlooked. Although molecular markers/targets likely play an important role in 
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intestinal tumors, the utility of these in diagnosis, prognosis, and therapy in companion 
animal species, with the exception of GIST and CD117 expression, is limited and further 
studies are auspicable to clarify their importance and pave the way for a standardized 
clinical use (Gillespie V et al, 2011). 
Measures of cellular proliferation include markers such as argyrophilic nucleolar organ-
izer regions (AgNORs). COX enzymes are responsible for prostaglandin synthesis, and 
COX-2 is overexpressed in many head/neck and genitourinary tumors, creating a pos-
sible therapeutic target. COX-2 has been identified in both benign and malignant small 
intestinal and colorectal epithelial tumors in dogs, although the number of positive cells 
varies and in some studies was very low (Knottenbelt C et al, 2006;  McEntee MF et al, 
2002). The value of COX inhibitors in the treatment of intestinal tumors is therefore dis-
puted. 
 
  
6.LYMPHOMA 
 
 
6.1  classification system  
 
Generally speaking lymphomas arise from clonal expansion of lymphoid cells with dis-
tinctive morphologic and immunophenotypic features. Many histologic systems have 
been used to classify non-Hodgkin lymphomas (NHLs) in humans, and some of these 
have been applied to lymphomas in dogs and other species. The NCI-Working Formula-
tion (the National Cancer Institute of the US proposed classification of non-Hodgkin’s 
lymphomas in  1982) and the updated Kiel system (Lennert K and Feller A, 1990) have 
been adapted to canine tumors with some success. The World Health Organization 
(WHO) also publishes a histologic classification scheme, which uses the revised Euro-
pean American lymphoma (REAL) system as a basis for defining histologic categories 
of hematopoietic and lymphoid tumors in domestic animals (Valli VE et al, 2002). This 
system incorporates anatomic, histologic, and immunophenotypic criteria (B- and T-cell 
immunophenotype), with the goal of enabling an accurate and reproducible diagnosis of 
specific neoplastic entities. This should theoretically assist in better tailoring treatment 
protocols and correlation with prognosis, besides an improved comparability of doctors’ 
findings. 
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Table 32-1 shows some of the WHO categories in three different surveys, including a 2-
year survey (2008-2009) of canine necropsy and biopsy cases at the University of Wis-
consin-Madison Veterinary Medical Teaching Hospital pathology service (Sueiro FA et 
al, 2004; Vezzali E et al, 2009); some of the less common categories in the WHO sys-
tem were not represented and are not listed. The WHO system is mainly focused of his-
topathologic  aspects and provides accurate and consistent reproducible diagnostic re-
sults similar to the system used in human pathology; accuracy among a group of 
pathologists examining 300 cases was at a 83% agreement score, and accuracy in 
evaluating the six most common diagnoses (80% of the cases) was 87% (Valli VE et al, 
2011). However, there is the need of further clinical studies in order to correlate the var-
ious categories of disease with biologic behaviour, response to treatment, and progno-
sis. Preliminary results indicate dogs with indolent lymphoma (e.g., marginal zone lym-
phoma, follicular lymphoma, B- or T-cell small cell lymphoma, T-cell–rich B-cell lym-
phoma, and T-zone lymphoma) maintain normal activity and appetite levels even during 
advanced stages of disease and experience long-term survival even with limited or no 
therapy (Stefanello D et al, 2011; Valli VE et al, 2006;  Flood-Knapik KE et al 2012). The 
NCI-WF was developed to allow investigators to “translate” among the numerous classi-
fication systems so that clinical trials could be compared in humans. Most of the studies 
agree that canine lymphomas tend to be to a great extent intermediate or high grade; 
however, diffuse immunoblastic forms appear to predominate in the United States, 
whereas the follicular large cell variant is prevalent in Europe. A comparison of Europe-
an and American classifications is warranted based on this discrepancy. 
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The WF categorizes tumors according to pattern (diffuse or follicular) and cell type (e.g., 
small cleaved cell, large cell, immunoblastic), but it does not include information about 
the immunophenotype of the tumor. The WF subtypes correlate with the biology of the 
tumor and the patient survival time. The updated Kiel classification includes the archi-
tectural pattern, morphology (centroblastic, centrocytic, or immunoblastic), and im-
munophenotype (B-cell or T-cell) of the tumor cells (Lennert K et al, 1990). In both sys-
tems, tumors can then be classified as low-grade, intermediate grade, or high grade 
malignancies. Low-grade lymphomas composed of small cells with a low mitotic rate 
typically progress slowly and are associated with long survival times but are ultimately 
incurable. High grade lymphomas with a high mitotic rate progress rapidly but are more 
likely to respond initially to chemotherapy and, in humans, are potentially curable. 
Several features of canine lymphomas become apparent when these classification sys-
tems are applied. The most striking difference between canine and human lymphomas 
is the scarcity of follicular lymphomas in the dog (Sueiro FA et al, 2004;  Vezzali E et al, 
2009). Some diffuse lymphomas in the dog may initially be follicular, but these may pro-
gress to the more aggressive, diffuse form by the time of diagnostic biopsy. The most 
common form of canine lymphoma is diffuse large-cell lymphoma, a high grade tumor 
most commonly of B-cell origin (Vezzali E et al, 2009; Valli VE et al, 2011; Carter RF et 
al,  1986). Only a small percentage of canine lymphomas (5.3% to 29%) are considered 
low-grade tumors. High-grade lymphomas occur frequently if diffuse large-cell lympho-
mas, classified as intermediate grade in the WF, are considered high-grade, as in the 
updated Kiel classification (in which they are labeled as diffuse centroblastic lympho-
mas). A documented difference exists in the prevalence of the various immunopheno-
types based on breed (Modiano JF et al, 2005). For example, Cocker Spaniels and 
Doberman Pinschers are more likely to develop a B-cell lymphoma, Boxers are more 
likely to have T-cell lymphoma, and Golden Retrievers appear to have an equal likeli-
hood of B- and T-cell tumors. To be clinically useful, these classification systems must 
eventually yield information about response to therapy, maintenance of remission, and 
survival. Some studies suggest that the subtypes in the WF can be correlated with sur-
vival, and the Kiel system may be useful for predicting relapse (Teske E  et al, 1994; 
Ponce F et al, 2004). In most studies, high-grade lymphomas achieve a complete re-
sponse (CR) to chemotherapy significantly more often than low-grade tumors. However, 
dogs with low-grade tumors may live a long time without aggressive chemotherapy (Val-
li VE et al, 2006; Flood-Knapik KE et al, 2012). Dogs with T-cell lymphomas (with the 
exception of low grade T-cell subtypes) have shown a lower rate of CR to chemothera-
py and shorter remission and survival times than dogs with B-cell tumors  (Vail DM et al, 
1996; Ruslander DA et al, 1997; Teske E, van  et al, 1994; Appelbaum FR et al, 1984). 
Furthermore, T-cell lymphomas tend to be associated with hypercalcemia (Rosol TJ, 
Capen CC, 1992; Weir EC et al, 1988), which can lead to severe complications. 
In the veterinary literature, 60% to 80% of canine lymphomas are of B-cell origin; T-cell 
lymphomas account for 10% to 38%; mixed B- and T-cell lymphomas account for as 
many as 22%; and null-cell tumors (i.e., neither B-cell nor T-cell immunoreactive) repre-
sent fewer than 5%. The development of monoclonal antibodies to detect specific mark-
ers on canine lymphocytes has made immunophenotyping of tumors in dogs routinely 
available in many commercial laboratories. Such techniques can be performed on paraf-
fin-embedded samples, from tissue microarrays, on cytologic specimens obtained by 
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fine-needle aspiration (FNA) of lesions, or by flow cytometric analysis of cellular fluid 
samples (e.g., peripheral blood, effusions) and lesion aspirates. 
The Rappaport classification system, proposed in 1956 for human NHLs, describes the 
architectural pattern (follicular or diffuse) and the cytologic features (well differentiated, 
poorly differentiated, or histiocytic) of lymphomas (Rappaport H et al,  1956;  Rappaport 
H, 1966). 
This system has not proved useful in providing prognostic information or in driving ther-
apy in dogs with lymphoma because of the low number of follicular lymphomas in dogs, 
the problematic “histiocytic” subgroup, and the failure to account for different morpho-
logic and immunologic cell types. One criticism of the Rappaport, Kiel, and WF classifi-
cation systems is that they fail to include extranodal lymphomas as a separate category. 
The WHO system includes anatomic location as a factor in determining certain catego-
ries. Although differences between nodal and extranodal tumors in biologic behaviour 
and prognosis are well recognized, comparative information about the histogenesis of 
these tumors is lacking. For example, in humans small-cell lymphomas arising from mu-
cosa-associated lymphoid tissue (MALT) are composed of cells with a different im-
munophenotype than that of other small-cell lymphomas (i.e., MALT lymphomas typical-
ly are negative for both CD5 and CD10). With the exclusion of cutaneous lymphoid ne-
oplasms, a detailed characterization of extranodal lymphomas in dogs has yet to be 
achieved. Although cutaneous lymphoma is a heterogeneous group of neoplasms that 
includes an epitheliotropic form resembling mycosis fungoides and a non-epitheliotropic 
form, most cutaneous lymphomas have a T-cell phenotype (Fry MM et al, 2003; Day 
MJ,1995). To conclude, it is important to determine the histologic grade of canine lym-
phomas as low (small lymphocytic or centrocytic lymphomas) or intermediate to high 
(diffuse large cell, centroblastic, and immunoblastic lymphomas) and the architecture as 
diffuse or follicular. Furthermore, determining the immunophenotype of the tumor pro-
vides useful information. Response rates to chemotherapy are, in general, better in an-
imals with B-cell tumors and intermediate- to high-grade lymphomas. Dogs with low-
grade lymphomas can have a long survival expectancy even without aggressive thera-
py. 
 
6.1.1  Intestinal lymphoma  
 
 
Among the intestinal tumors of hematopoietic cell origin, lymphoma is the most common 
in  dogs (Guiford WG et al, 1996), with primary intestinal lymphoma being less common 
than  the multicentric form (Head et al, 2002). Although it was previously thought that 
primary  intestinal lymphomas in dogs were of B-cell origin, recent reports have indicat-
ed that the  majority of canine intestinal lymphoma are of T-cell origin (Coyle KA et al, 
2004; French RA  et al, 1996; Steinberg H et al, 1995). Of 49 dogs with intestinal lym-
phoma, 38 cases were of  T-cell phenotype with epitheliotropism, three cases were 
nonepitheliotropic lymphoma of  B-cell origin, and eight cases could not be immunophe-
notyped. T-cell lymphomas of  intestinal origin have been divided into two types based 
on the morphological  characteristics of the tumor cells: small- to moderate-sized lym-
phoma showing  epitheliotropic behavior, and moderate- to large-sized lymphoma with 
or without  epitheliotropism. The former type has been classified as intestinal T-cell lym-
phoma  according to the World Health Organization (WHO) classification system (Valli 
VE et al,  2002) and is similar in cell morphology, immunophenotype, and epitheli-
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otropism to  previously reported cases (Coyle KA et al, 2004; French RA et al, 1996; 
Steinberg H et al,  1995). Epitheliotropic T-cell lymphoma of the intestinal tract, also 
known as intestinal T-cell  lymphoma, has been described as a slowly progressive small 
cell lymphoma of the enteric  tract, which appears to arise from a background of chronic 
inflammatory bowel disease  (French RA et al, 1996). 
K. Ozaki et al (2006) described mast cell tumors of the canine intestinal tract. However,  
human intestinal T-cell lymphomas, especially the pleomorphic moderate and large cell  
types, are usually accompanied by eosinophil infiltration, and eosinophil infiltration has  
been observed in peripheral/extranodal T-cell lymphomas in animals. These morpholog-
ical  characteristics were very similar to those of moderate- to large-sized T-cell lym-
phoma of  intestinal origin. These results suggest that, in dogs, T-cell lymphomas of in-
testinal origin  resemble mast cell tumors of intestinal origin with respect to cell structure 
and eosinophil  infiltration. Canine intestinal T-cell lymphoma without epitheliotropism 
has been reported  (Ozaki K et al, 2006). Alimentary lymphoma of dogs is accompanied 
by lymphoplasmacytic  infiltration (Couto et al, 1989) An epitheliotropic alimentary form 
of canine T-cell lymphoma  has also been found to be concomitant with lymphocytic-
plasmacytic enteritis (French RA et  al, 1996).Alimentary lymphoma has aggressive be-
havior and a poor prognosis (Couto CG et  al, 1989).Epitheliotropism was not related to 
prognosis. Canine T-cell lymphomas,  characterized by small to large cell types and eo-
sinophil infiltration, developed in the small intestine. Diagnostic pathologists should be 
aware of T-cell lymphoma as a differential  diagnosis for intestinal round cell tumors with 
eosinophilic infiltrates. Since these tumor cells  were very similar to mast cell tumors of 
gastrointestinal origin, immunostaining for mast cell  and lymphocyte markers was re-
quired for definitive diagnosis. 
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 7. DIAGNOSTIC PROCEDURES 
 
7.1 History and Clinical Signs  
 
 
Dogs with GI or alimentary lymphoma are usually presented with aspecific  GI signs. 
The duration of the preclinical stage typically averages 6 to 8 weeks but can range from 
less than 1 day to several months (Berrocal A et al, 1989; Bennett PF, et al, 2002; Wil-
liams LE et al, 2003). 
Clinical signs include: weight loss, diarrhea, vomiting, and anorexia and less frequently 
melena, anemia, and hypoglycemia (mainly if smooth muscle tumors). 
Clinical signs often relate to location of the tumor within the GI tract. Proximal lesions 
more commonly result in vomiting, small intestinal lesions in weight loss, and large 
bowel lesions in hematochezia and tenesmus (Gröne A et al, 1994; Hause WR et al, 
1981). Dogs may present clinical signs relating to intestinal obstruction, such as anorex-
ia, weight loss, and vomiting. Although uncommon, perforation and septic peritonitis can 
occur (Messinger JS et al. 2009). Smooth muscle tumors are located within the muscu-
lar layer of the intestines and not within the lumen and evidence of GI bleeding is often 
absent, but anemia and melena have been reported (Williams LE et al, 2003). 
Canine lymphoma also may be associated with paraneoplastic syndromes (PNSs),  
which are neoplasm-associated alterations in bodily structure and/or function that occur 
distant to the tumor. They are a diverse group of clinical aberrations that are associated 
with the non-invasive actions of the tumor. Often the PNS parallels the underlying ma-
lignancy, therefore a successful treatment of the tumor leads to disappearance of the 
PNS. Alternatively, recurrence of the PNS after an apparent successful treatment sig-
nals a tumor recurrence and often significantly precedes a clinical detection of the tu-
mor. 
PNSs are often the first sign of malignancy, and the PNS may be a hallmark of a specif-
ic tumor histotypes. Therefore, an understanding and appreciation for the types and un-
derlying causes of these syndromes are paramount for early cancer detection and ap-
propriate therapy. In addition, a PNS may result in greater morbidity than that associat-
ed with the actual tumor. The causes of PNSs are quite variable; they are usually 
caused by the production of small molecules (e.g., hormones, cytokines, or peptides) 
that are released into the circulation to cause effects at distant sites or by immune 
cross-reactivity between malignant and normal tissues. Some PNSs are due to func-
tional mutations that result in over-expression of the small molecules in question, 
whereas many non-endocrine PNSs are of unknown etiology. PNSs are recognized 
commonly in both human and companion animal cancer patients 
 
7.1.1 Physical examination 
 
 
An abdominal mass may be palpated on initial examination in approximately 20% to 
40% of dogs with lymphoma (Couto CG, et al, 1989) and 20% to 50% of dogs with non-
lymphomatous solid intestinal tumors (Crawshaw J, et al, 1998; Paoloni MC, et al, 2002; 
Birchard SJ et al 1986). 
Pain and fever were reported in 20% of dogs with lymphoma in one study (Couto CG, et 
al, 1989). Digital rectal examination may identify masses or annular strictures due to 
rectal tumors or polyps in as high as 63% of dogs (Paoloni MC, et al.,  2002; Church EM 
et al 1987; Kosovsky JE, et al, 1992) 
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7.2 Clinical pathology  
 
7.2.1 Complete Blood Count 
 
 
Anemia is common in dogs with intestinal tumors and is often not characterized but may 
occur in conjunction with melena and elevated blood urea nitrogen (BUN). In most stud-
ies, anemia is present in nearly 40 % of affected dogs. Leukogram changes are also 
common, including leukocytosis in 25 to 70 percent of dogs (Crawshaw J, et al, 1998;  
Kapatkin AS, et al, 1992; Carreras JK, et al, 2003; Kosovsky JE, et al 1988). Left shift as 
well as monocytosis may be observed  in some patients (Birchard SJ et al 1986). 
 
7.2.2 Chemistry Profile 
 
 
Biochemical abnormalities between dogs with different intestinal tumors are similar. As 
a result of malabsorption, hypoproteinemia may be present in one-fourth to one-third of 
patients. In a study by Price et al (1991) hypoalbuminemic dogs being treated for multi-
centric lymphoma had 50 percent shorter remission times than dogs that were present-
ed with normal albumin levels. Albumin plays an important role in physiological function, 
including drug binding and transport, as well as maintenance of vascular oncotic pres-
sure (Guilford et al, 1996; Hughes D., 2000). It works also as an antioxidant, i.e. a scav-
enger of free radicals, which are proved to play a role in the pathogenesis of neoplastic 
diseases (Halliwell B et al, 1990).  Although a trend has been observed between surviv-
al rates and increased albumin level at presentation, no significant correlation has been 
demonstrated; the effect of low albumin on survival time for gastrointestinal lymphoma 
remains unclear. 
 Other common abnormalities include elevated liver enzymes, specifically alkaline 
phosphatase in 15% to 33% of dogs (Crawshaw J et al, 1998; Kapatkin AS, et al, 1992; 
Paoloni MC, 2002; Birchard SJ, 1986; Carreras JK, et al,2003; Kosovsky JE, et al 
1988). In a study, Joseph David Frank and collegues  (2007) found that a significant 
portion of examined dogs had hypocalcemia at presentation, although in all but one of 
these dogs calcemia was normal if corrected for hypoalbuminemia, making this finding 
of little clinical significance. 
 
7.2.3 Anatomopathological Perspectives of the Gastrointestinal Tract 
 
7.2.3.1 Cytology  
 
 
As with other anatomic sites, cytology of the intestinal tract can help to differentiate 
among major tumor types. Cytologic evaluation plays several important roles in veteri-
nary oncology that aid in clinical decision making, including making a temptative or de-
finitive diagnosis, planning diagnostic and treatment strategies, determining prognosis 
through staging, detecting recurrence, and monitoring response to therapy.  An under-
standing of the advantages and limitations of cytologic evaluation is necessary in order 
to effectively apply this diagnostic modality in clinical oncology. 
Advantages of cytologic evaluation include the ability to study the morphologic appear-
ance of individual cells, the relatively low risk of this procedure to the animal patient and 
the lower cost compared with biopsy, and the promptness of results. 
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Cytologic evaluation has nonetheless several limitations. The amount of tissue sampled 
is small compared with that obtained from a biopsy, resulting in cytologic samples pos-
sibly not fully representative of the lesion. Samples quality may be poor because of fac-
tors intrinsic to the lesion or poor collection technique. Importantly, the inability to evalu-
ate architectural relationships among cells in cytologic samples gives rise to difficulties 
in differentiating  between reactive and neoplastic processes. Examination of histologic 
samples, in which tissue architecture is preserved, may be required to make a definitive 
diagnosis of neoplasia, determine tumor type, and assess the extent of the lesion, in-
cluding metastasis. Even then, some ancillary tests like immunohistochemical staining 
or tests for clonality may be required. 
Often cytologic evaluation precedes a biopsy and provides information that assists in 
formulating subsequent diagnostic and treatment options. 
Some tumors, such as lymphomas, may be diagnosed using exclusively a cytologic 
evaluation, and treatment can be initiated without the need to collect an histologic sam-
ple. For other tumors, such as well-differentiated hepatocellular carcinomas, a cytologic 
examination permits to narrow the spectrum of differential diagnoses, making it possible 
for the histologic evaluation to provide a definitive diagnosis. Cytology can often help to 
classify a tumor as epithelial, mesenchymal, or discrete round-cell; this may be suffi-
cient for a preliminary discussion with the owner about diagnosis and prognosis. Stag-
ing the malignancy, monitoring therapy, and detecting recurrence using a cytologic 
evaluation is more easily accomplished once a definitive diagnosis has been made and 
cytomorphologic features of the tumor have been described. 
An endoscopic biopsy of the duodenal mucosa has been an important tool in the diag-
nosis of chronic diseases of the small intestinal tract in dogs and cats for at least 10 
years. However, obtaining a tissue sample may sometimes be challenging, as evi-
denced by the sheer number of techniques that have been reported for endoscopic bi-
opsies. In addition, various types of flexible biopsy forceps are available, and the size 
and depth of tissue sample that are obtained depend on the characteristics of the for-
ceps used. Therefore, it is not surprising that the quality of tissue sample obtained en-
doscopically can vary widely, and this variation has led to concerns that endoscopically 
obtained tissue samples can be often inadequate for a diagnosis. Infact, inadequate bi-
opsy samples have been cited as a cause of erroneous diagnoses in veterinary medi-
cine. This concern about the quality of endoscopically obtained tissue samples seems 
particularly important for the duodenal tract. Firstly, because of the nature of the duode-
nal mucosa, good quality duodenal samples seem to be relatively harder to obtain as 
compared with other areas of the alimentary tract and more prone to handle artifacts 
than do gastric and colonic mucosa samples. Secondly, upper gastrointestinal tract dis-
ease causing vomiting or diarrhea often involves the duodenal mucosa, in some cases 
even more than the gastric mucosa, making it important for a correct diagnosis an ex-
cellent sample of duodenal mucosa. 
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7.2.3.2 Cytology of Lymphoma 
 
 
 Small, well-differentiated lymphocytes measuring 1 to 1.5 times the diameter of an 
erythrocyte in the dog compose approximately 90% of the population in lymph nodes. 
The chromatin of these cells is densely clumped with no visible nucleoli. Cytoplasm is 
scant. These cells are the darkest staining of all lymphocytes. Medium and large lym-
phocytes, whose nuclei measure 2 to 3 times the erythrocytic diameter, are usually pre-
sent in low numbers (5% to 10%). 
Their nuclei have a fine, diffuse, and light chromatin pattern. Nucleoli may be prominent. 
The cytoplasm is more abundant and often basophilic. Mature plasma cells represent a 
small portion of the cells found. Their chromatin is densely clumped and often the nu-
cleus is  eccentrically placed within the abundant, deeply basophilic cytoplasm.  A pale 
area or halo is seen adjacent to the nucleus, which indicates the Golgi zone. Occasional 
macrophages (histiocytes) appear as large mononuclear cells with abundant light cyto-
plasm, often containing cellular debris. Nuclear chromatin is finely stippled and nucleoli 
may be found in activated macrophages. Mast cells and neutrophils also may be pre-
sent in low numbers.  
Inflammatory cells are categorized according to the grading system, with a grade of 2 or 
more indicating the corresponding degree of significant inflammation. The grading sys-
tem is used to express the presence and magnitude of the neutrophilic or lymphocytic-
plasmacytic inflammatory constituents. Severe lymphocytic enteritis may be difficult to 
differentiate from malignant lymphoma when medium to large lymphocytes are promi-
nent. A comparative correlation with the histologic findings is mandatory.  
 
Cytologic Protocol and Terms Used to Evaluate Lymphoma Cases  (Teske et al, 1994). 
 
Determine the cell size based on comparison of the nucleus to the size of an erythro-
cyte. 
• Small: 1-1.5 3 RBC 
• Medium: 2-2.5 3 RBC 
• Large: .3 3 RBC 
Determine the shape of the nucleus and its placement within the cytoplasm. 
• Round: Circular with no indentations 
• Irregularly round: Few indentations or convolutions 
• Convoluted: Several deep indentations 
• Clefted: Single deep indentation 
• Central vs. eccentric placement 
Determine the number, size, visibility, and location of nucleoli within the neoplastic lym-
phocytes. 
• Single vs. multiple 
• Large vs. small 
• Indistinct: Not visible or barely perceivable 
• Prominent: Easily visible 
• Central vs. marginal or peripheral placement 
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Describe the cytoplasm by amount and color. Be sure to note presence of Golgi zone  
or granulation. 
• Scant: Small rim around nucleus 
• Moderate size: Amount intermediate between scant and abundant 
• Abundant: Nearly twice the size of the nucleus 
• Pale: Light basophilia or clear 
• Moderate basophilia: Color intermediate between pale and dark blue 
• Deep basophilia: Royal blue or darker 
Estimate the mitotic index by looking at 5 cellular fields under 40 mm or 50 mm objec-
tives.  
• Low: 0-1 mitotic figures per 5 fields 
• Moderate: 2-3 mitotic figures per 5 fields 
• High: 3 mitotic figures per 5 fields 
Tumor grade is morphologically based on cell size and mitotic index. 
• Low grade: Low mitotic index and small cell size 
• High grade: Moderate or high mitotic index and medium or large cell size 
 
 
Lymphoma comprises many variants. Definitive diagnosis of lymphoma based on cyto-
logic examination is often possible; however, in some types of lymphoma or in certain 
discrete round-cell neoplasms, it is the homogeneity of the population, rather than its 
morphology, that suggests a neoplastic process. In lymphoid organs or other tissues in 
which there is a reactive or polyclonal infiltrate of lymphocytes, small lymphocytes 
should make up more than 50 percent of the lymphoid cells, even as the proportion of 
large and intermediate lymphocytes increases and plasma cells and other inflammatory 
cells are found in these reactive lesions. As the proportion of intermediate and large 
lymphocytes approaches or exceeds 50%, it becomes more difficult to differentiate be-
tween a reactive and neoplastic process; this is especially true for the spleen and cer-
tain lymph nodes, such as mandibular and mesenteric nodes, that are continuously ex-
posed to antigens. Because of this, sampling of other nodes or tissues is preferred. In 
addition, cats can show strong lymphocytic responses that can cytologically resemble a 
lymphoma. In contrast, there are certain types of lymphoma, such as T-cell-rich B-cell 
lymphomas and Hodgkin’s-like lymphoma, that contains a mixture of clonal (neoplastic) 
and polyclonal (non-neoplastic) populations of lymphocytes. When a diagnosis of lym-
phoma is not definitive from the cytologic specimen, additional procedures should be 
carried out, including biopsy with histologic evaluation, immunophenotyping, assess-
ment of clonality, or a combination of these. 
Lymphoma can be easily diagnosed cytologically when large or intermediate lympho-
cytes comprise the majority of the nodal population. Large and medium-sized lympho-
cytes are defined as those larger than or the same size as a neutrophil, respectively, or 
that are greater than two times or one-and-a-half to two times the diameter of an eryth-
rocyte, respectively. Cytologic types include immunoblastic or centroblastic types, com-
posed of large cells with visible nucleoli and deeply basophilic cytoplasm, and types 
composed of medium-sized cells often having indistinct nucleoli. Mitotic figures and tin-
gible-body macrophages, which are macrophages containing nuclear debris from tumor 
cells, may also be increased, but this is not a defining characteristic. 
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Cytologic diagnosis of small cell lymphoma is more challenging, especially in tissues 
such as lymph nodes and spleen with a resident population of small lymphocytes or in 
tissues such as liver and small intestine in which lymphocytic inflammation is common. 
In these cases, additional diagnostic tests are required for confirmation and may include 
one or more of the following: histologic examination, preferably of a whole node or full-
thickness piece of intestine; immunophenotyping by immunocytochemical/histochemical 
staining or flow cytometry; and polymerase chain reaction (PCR) for antigen receptor 
rearrangement to detect clonality. 
Since lymphocytes are fragile, free nuclei and cytoplasmic fragments are frequently ob-
served in aspirates of lymphoma; however, these features can be found in samples 
from reactive lymphocytic populations and are not criteria for neoplasia. 
Infrequently, neoplastic lymphocytes are highly pleomorphic and exhibit moderate to 
marked anisocytosis, indented or deeply clefted nuclei, ameboid nuclei, multinuclearity, 
cytoplasmic vacuoles, and aberrant phagocytic behavior. When present, a few, some, 
or most of the neoplastic lymphocytes in a given tumor may have these features and 
may be mistaken for neoplastic histiocytes (Jaffe ES, 2009). Sometimes neoplastic lym-
phocytes contain fine or coarse pink cytoplasmic granules, suggestive of a T- or NK-cell 
phenotype. In large granular lymphomas, the lymphocytes contain large, coarse, pink 
granules and are thought to be cytotoxic T- or NK-cells. 
Views differ regarding the accuracy of cytological diagnosis of enteropathy-type lym-
phomas.  In one study done by Bonfanti and collegues, results of fine-needle biopsy of 
deep abdominal organs were consistent with the diagnosis of inflammatory versus neo-
plastic disease in 89% of cases (Bonfanti at al, 2004). However, in another study by the 
same authors, cytological examination of gastrointestinal tumors was consistent with 
histological findings in only 72% of cases (Bonfanti et al, 2006). Although histology is 
preferred for accurate cell typing and grading, cytological examination has been identi-
fied as an accurate means to diagnose canine lymphoma (Vail DM et al, 2001). 
 
7.2.3.3 Histology 
 
 
Although histological examination of all layers and full thickness biopsies of GI wall re-
mains the gold standard the diagnosis and treatment of gastrointestinal disease in the 
dog and cat are increasingly based on the collection and interpretation of mucosal biop-
sy samples obtained endoscopically from one or more gastrointestinal sites. There are 
many stages in this process in which errors may be occur, thereby influencing the clini-
cal outcome. These stages include the endoscopic biopsy procedure, the processing 
and embedding of the small and fragile tissue samples, and the microscopical interpre-
tation of the tissue changes by the diagnostic pathologist (Willard et al., 2001, 2002). 
For many clinicians and pathologists, the histopathological interpretation has proved to 
be the most contentious and frustrating step in the diagnostic sequence. This interpreta-
tion may be complicated by inadequacies in the number and quality of the tissue sam-
ples, by fragmentation and unfavourable orientation of these samples during pro-
cessing. 
The prognosis of alimentary lymphoma is poor, compared to the multicentric form, re-
gardless of the treatment. Therefore, it is important to make a definitive diagnosis of al-
imentary lymphoma. In many cases lymphoma is currently diagnosed on the basis of 
cytological or histophatological findings.  However, it is  frequently observed that the se-
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vere lynphocytic-plasmacytic inflammation that occurs in conjunction with alimentary 
lymphoma makes it difficult to distinguish lymphocytic-plasmacytic enteritis (LPE) from 
alimentary lymphoma, especially when the tumor cells are well differentiated (e.g., low 
grade lymphoma). 
Usually, the pathologist diagnoses an alimentary lymphoma in a sample with the follow-
ing characteristics: atypical lymphoblast infiltration, infiltration of lymphocytes with de-
struction or  replacement of the normal architecture of the epithelial cells layer, lamina 
propria or crypta. However, a histopathological distinction of an alimentary lymphoma 
from lymphocytic-plasmacytic enteritis is often difficult. 
 
7.2.3.4 Immunohistochemistry  
 
 
Immunohistochemical staining is carried out on formalin-fixed, paraffin-embedded tissue 
or, less commonly, on frozen sections. Immunocytochemistry (ICC) uses the same 
methods and reagents but on fine-needle aspirates. Antibodies to specific proteins are 
applied to the tissue, generally followed by a secondary antibody of a different species 
than the patient or the primary antibody. 
The secondary antibodies are conjugated to enzymes that catalyze a color change 
when a substrate is added. This method allows pathologists to identify individual cells 
that do or do not express the protein of interest and to put these cells in the context of 
tissue architecture. 
In veterinary oncology, IHC is most commonly used to distinguish sarcomas from carci-
nomas and to phenotype lymphomas. The first application involves staining tumor sec-
tions with antibodies to the cytoskeletal proteins vimentin and cytokeratin. 
Vimentin is found in mesenchymal origin tumors (e.g., osteosarcomas, fibrosarcomas). 
Cytokeratin is expressed by epithelial origin cancers (carcinomas). Although the distinc-
tion between these two types of tumors is generally straightforward, it is common to re-
quest vimentin/cytokeratin staining when results are not clear. 
IHC is particularly important in subclassifying lymphoma. The 2008 World Health Organ-
ization (WHO) classification of lymphomas describes more than 40 lymphoproliferative 
disorders (lymphoma and leukemia) in humans (Jaffe ES, 2009).  All subclassifications 
begin with phenotype (B- versus T-cell). The origin and biologic behavior of different 
subtypes of lymphoma is different enough that it is not scientifically justified to consider 
lymphoma as a single disease. Therefore, when conducting therapeutic trials, epidemio-
logic studies, and any other types of analyses on canine lymphomas, it will be neces-
sary to examine individual subtypes separately. 
The antibodies used to determine the B- or T-cell origin of lymphoma in formalin-fixed 
sections are anti-CD3 (which identifies T-cells) and one of several anti–B-cell antibod-
ies, including CD79a, Pax5, and CD20. All of these antibodies recognize the cytoplas-
mic portions of the target antigen and the process of fixation permeabilizes cells to allow 
access of antibodies to these epitopes. The antibodies also recognize conserved se-
quences of proteins and are therefore useful in a variety of different species. Further 
sub-classification of lymphoma is possible based on the distribution of neoplastic cells 
within the lymph node. For example, there is a number of neoplasms of mature B-cells, 
suche as mantle-cell and follicular lymphoma (FL), with very different outcomes. These 
lymphomas can be differentiated by examining the architecture of a lymph node stained 
with B-cell antibodies. In human patients, they can also be differentiated by flow cy-
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tometry or cytogenetic studies. The human classification has been applied to canine 
lymphoma by a consortium of pathologists who reached a broad albeit not complete 
agreement about histologic subtypes (Ponce F et al, 2004). 
Unfortunately, the paucity of data on the biologic behaviour of these subtypes in dogs 
doesn’t allow for them to be used in a clinical setting. IHC, however, allows the 
pathologist to define positive cells into the architecture of the node. Veterinary 
pathologists recognize many of the WHO categories of lymphoma, including diffuse 
large B-cell lymphoma, FL, and mantle-cell lymphoma. One study systematically evalu-
ated outcomes using contemporary classifications and found that small cell T-zone lym-
phoma had the most favorable outcome, whereas Burkitt-like B-cell lymphoma had the 
worst one (Ponce F et al, 2004). This study, although small, revealed the value of clas-
sifying and subclassifying lymphomas using contemporary standards. More recently, an 
investigation of canine indolent T-cell lymphoma, diagnosed by histology coupled with 
IHC, revealed that treatment of this form of lymphoma with a CHOP-based protocol re-
sulted in the same outcome as treatment with chlorambucil and prednisone. 
This is the first study clearly demonstrating the utility of histology and IHC in guiding 
treatment decisions (Flood-Knapik KE  et al, 2012). 
 
 
 
 
 
 
7.2.5 Molecular biology 
 
The complete genetic code, or DNA sequence, is present within every cell in the body. 
The effective genetic information that uniquely defines each cell type within the body is 
defined by the genes expressed (transcribed) as mRNA. The expression of mRNA is 
more responsible for the phenotype of a cancer than the individual genes and mutations 
harbored by the tumor. When assessing the level of expression of one or a few genes, 
real time PCR is most commonly used. Assessment of the global level of gene expres-
sion is carried out with microarrays and is called gene expression profiling. 
Both methods measure relative expression of message when compared to a control 
gene whose expression is thought to be more or less constant in all cells and universal. 
These methods are both likely to be replaced over the next 10 years with new technolo-
gies, which will allow investigators to count the absolute number of genes or transcripts 
in a sample. 
Real-time PCR (also called Q-PCR) refers to the quantitative measurement of DNA, ei-
ther single genes, or more commonly, RNA that has been reverse transcribed to cDNA. 
The principle of real-time PCR is that DNA is amplified using primers, just as in a routine 
PCR reaction, but at each round of amplification, fluorescence relative to the amount of 
PCR product is quantified. Unlike endpoint PCR, in which the reaction runs to comple-
tion and the product is separated by size, real-time PCR is highly quantitative. 
The two main methods for quantifying DNA in real-time PCR have different advantages 
and disadvantages. The simplest and least expensive method is the use of the DNA-
binding dyes, such as SYBR green. This dye fluoresces when it intercalates into DNA. 
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Therefore, at each round of amplification, more dye is intercalated and the degree of 
fluorescence increases. 
Eventually, the fluorescence reaches saturation, but the endpoint is less important than 
the log phase of DNA increase. The amount of starting material is compared between 
samples by determining at which amplification cycle the degree of fluorescence crosses 
a given threshold. SYBR green will intercalate into any DNA product, so this method is 
only accurate when the primers are highly specific and amplify only one gene product. 
An alternative method uses fluorescently labeled DNA probes. These are short seg-
ments of DNA complementary to the target sequence between the two primer sites. A 
fluorescent molecule attached to the probe is quenched until the 5′ to 3′ exonuclease 
activity of the Taq polymerase releases the fluorescent molecule. As the amount of PCR 
product increases proportional to the starting material, the amount of fluorescence in-
creases. The advantage of the probe method is that the use of three primers, instead of 
two, provides more specificity to the reaction. In order to detect a product, these three 
different segments of DNA need to bind to the target sequence in three separate places. 
The assay may be less robust at low target numbers and is slightly more expensive, but 
it is also significantly more specific. This assay with its increased specificity was used by 
Yamazaki and collegues (2008) to quantify individual neoplastic lymphocytes in a back-
ground of heterogenous lymphocytes and thus quantify minimal residual disease. 
Real-time PCR can quickly allow for precise quantification of mRNA levels within sam-
ples and has a number of defined clinical applications. It is commonly used in the quan-
tification of aberrant oncogenic fusion products. Promyelocytic leukemia gene–retinoic 
acid receptor (PML-RAR) fusion transcripts in acute promyelocytic leukemia (APL) are 
identified by this method in humans (Gallagher RE et al, 2003) and can be used to de-
fine molecular remission in patients with APL. Molecular remissions are defined by the 
absence not only of a clinically detectable disease but also of any tumor-associated 
transcript in blood, bone marrow, or lymph node. Achieving a molecular remission in pa-
tients with leukemias and lymphoma is a superior measure of prognosis over clinical 
assessments of remission that are based on clinical examination, imaging techniques, 
or histologic or cytologic assessments of at-risk tissues. 
A report by Kaneko et al. (2009) has suggested the application of molecular-based 
methods as diagnostic tools for canine alimentary lymphoma; these diagnostic tools are 
useful for the detection of a latent alimentary lymphoma. In a study of Fukushima H. et 
al. (2009),  the overall sensitivity of the PARR analysis in diagnosing canine alimentary 
lymphoma was 66%, which was lower than that of other lymphoid malignancies. 
 
7.3 Plain and Contrast Abdominal Radiographs 
 
 
In dogs with intestinal lymphoma, concurrent enlargement of liver, spleen, and/or mes-
enteric lymph nodes may be found (Couto CG et al, 1989). Plain abdominal radiographs 
may reveal an abdominal mass in approximately 40% of both dogs and cats, although 
some reports are higher for solid tumor types and lower for lymphoma. Intestinal lym-
phoma may be more difficult to identify on plain radiography because of other organ in-
volvement, peritoneal effusion, or diffuse intestinal lesions. An obstructive pattern may 
also be seen on plain radiographs, with incidence ranging from 10 to 75 percent. Con-
trast radiography, although now partially replaced following advances in ultrasound, has 
often been used to evaluate patients with signs of primary GI disease. Contrast radiog-
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raphy can help to identify an obstruction, localize a tumor, and view areas of the GI tract 
that are difficult to image with ultrasonography because of gas accumulation. Contrast 
radiographs may reveal filling defects in approximately half the cats and dogs with GI 
neoplasia (Birchard SJ et al,  1986). In dogs with GI lymphoma, all 12 dogs examined 
had abnormal contrast series.  
 
7.4 Thoracic Radiographs 
 
 
Thoracic radiographs are critical to the complete evaluation of the cancer patient. For 
dogs with non-lymphomatous intestinal tumors, yield is low with very few patients pre-
senting with pulmonary metastasis.  This may be due to a bias in reporting, because 
many reports detail outcome of treatment and patients with metastatic disease may not 
receive treatment. In fact, many case series report no evidence of metastasis on initial 
evaluation for solid tumors of the intestine in dogs. 
 
7.5 Abdominal Ultrasound 
 
 
Ultrasound allows a non-invasive localization of the tumor and identification of other 
sites of metastasis/involvement. It also can guide needle aspiration or needle biopsy or 
assist in treatment planning. Ultrasound is a more sensitive diagnostic test than radio-
graphs for identifying a mass (Rivers BJ et al, 1997). Ultrasound is also less time-
consuming than contrast radiography, and availability together with improved operators’ 
skills for the former have diminished the need for the latter. 
Ultrasound findings in dogs with intestinal neoplasia most consistently include thicken-
ing and loss of the normal layers in the bowel wall (Penninck DG et al, 2003). 
Degree of thickening, distribution of lesions, and symmetry are also used to help differ-
entiating neoplasia from non-neoplastic disease (Gaschen L, 2011). 
Intestinal lymphoma in dogs often results in long segments of involved bowel.  
In one study, two-thirds of dogs with intestinal adenocarcinoma had hypoechoic tumors, 
and most had a decreased motility. Masses averaged 4-cm in diameter with a median 
wall thickness of 1.2 cm (Patnaik AK et al,1977). Mast cell tumors have an eccentric 
appearance with alteration, but not loss, of wall layering, commonly involving the mus-
cularis propria. Smooth muscle tumors are characteristically large (median diameter 4.8 
cm) and anechoic or hypoechoic. Leiomyomas may have a smooth contour (Myers NC 
and Penninck DG, 1994). Ultrasound has also proven useful in differentiating neoplastic 
from non-neoplastic intestinal disease. Dogs with tumors have significantly thicker intes-
tinal walls, and 99 percent have a loss of wall layering, compared to a maintenance of 
wall layering in 88 percent of dogs with non-neoplastic disease. In fact, dogs with a loss 
of wall layering are more than 50 times more likely to have a tumor than enteritis. Addi-
tionally, dogs with an intestinal wall thicker than 1 cm and those with focal lesions are 
nearly 4 times and 20 times as likely to have a tumor, respectively. Nevertheless, the 
diagnosis is not always straightforward: fungal masses, as in pythiosis and histoplas-
mosis, that can mimic neoplasia and a lymphadenopathy can also be caused by an in-
fectious or inflammatory bowel disease. In general, neoplasia exhibits more dramatic 
thickening with loss of wall layering and greater lymph nodal enlargement, as well as 
more frequent focal lesions than non-neoplastic intestinal diseases. 
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7.6 Endoscopy and Laparoscopy 
 
 
Minimally invasive methods of collecting tissues to aid in diagnosis are increasingly 
used. Endoscopic findings in dogs with intestinal lymphoma include an irregular cobble-
stone or patchy erythematous appearance to the duodenal mucosa and poor distensibil-
ity and elasticity of the duodenal wall (Miura T et al, 2004). Significant inter-observer 
variation may occur in the interpretation of biopsy samples. In one study, blinded 
pathologists assigned a degree of mucosal cellular infiltrate as severe as neoplasia in 
five clinically normal research dogs. Inter-observer variation is likely to be more pro-
nounced with small tissue samples and this is a limitation of these less invasive ap-
proaches. 
 
7.7 Exploratory Laparotomy 
 
 
When non-invasive or minimally invasive diagnostics in a dog with persistent signs of GI 
disease fails, an exploratory laparotomy may be the next step. This procedure allows 
the direct visualization of all abdominal viscera and the acquisition of full thickness biop-
sies of all segments of intestines and other viscera. Patients with resectable solid tu-
mors may be both diagnosed and treated in one single procedure with resection and 
anastomosis. In a series of dogs with GI lymphoma, endoscopic biopsies were some-
times difficult to interpret because of lymphoplasmacytic infiltrate, but biopsies obtained 
via laparotomy confirmed the diagnosis in all cases undergoing surgery (Couto CG  et 
al, 1989). As a side note, it is important in the clinical practice to avoid the pitfall of au-
tomatically considering carcinomatosis as an indication for euthanasia.
8. AIM OF THE WORK 
 
 
This study was focused on the subtype of intestinal lymphoma defined as epitheliotropic 
or enteropathy-type lymphoma (Valli, 2007), which is the major differential diagnosis of 
IBD. In epitheliotropic lymphoma, neoplastic lymphoid cells invade the intestinal mucosa 
with a diffuse pattern, leading to an impairment of the normal functions of digestion and 
absorption. In clinical practice, gastro-enteric signs are similar to those present in in-
flammatory enteropathies. The differential diagnosis between IBD and alimentary lym-
phoma based on clinical, diagnostic imaging and laboratory findings can be very chal-
lenging. Patients with alimentary lymphoma show clinical symptoms and signs that are 
all comparable to patients with inflammatory enteropathy. The endoscopic examination 
and biopsy of the alimentary tract is paramount to differentiate between IBD and lym-
phoma and consequently deliver the appropriate treatment.   
In most cases of canine lymphoma, which are high-grade subtypes, the presence of a 
single population of immature lymphoid allows an unproblematic cytologic diagnosis. 
However, some subtypes of lymphoma (e.g. small-cell lymphoma, follicular lymphoma, 
etc) require histopatology for a definitive diagnosis because of the inherent limitations 
associated with cytology. Additional investigation using lineage-specific antibodies may 
require immunocytochemistry, immunohistochemistry and flow cytometry to differentiate 
between B- and T-cell lymphomas and can provide some information regarding progno-
sis.  
In enteropathy-type lymphomas, cytology or histology may fail to confirm the diagnosis 
and a different approach may be required. Surgical full thickness biopsies via laparato-
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my and enterothomy is generally considered the best diagnostic methods. However, this 
test is rarely accepted by the owner in a clinical setting and endoscopic biopsies are 
generally considered more feasible. This study is focused on the early identification and 
diagnosis of enteropathy-type lymphoma in the clinical practice, using and endoscopic 
approach. We outline some cytological guidelines that can be used to differentiate be-
tween IBD and lymphoma on squash-prep endoscopic biopsy. The aim of our study is to 
evaluate the diagnostic accuracy of cytological results in the differential diagnosis be-
tween IBD and lymphoma in dogs on endoscopic biopsies. Since a single gold standard 
is not available for this scope, the integration of history, physical findings, diagnostic im-
aging, endoscopic features, intestinal cytology, intestinal histology and immunohisto-
chemistry along with a follow-up of each case, was implemented by an expert in gastro-
enterology in order to reach a definitive diagnosis. Moreover , although the evaluation of 
histopathologic results is not within the aims of the present work and I did not personally 
perform histopathology, we report and discuss here the results obtained from the histo-
pathological evaluation and immunohistochemistry of endoscopic biopsies, in order to 
verify and compare the diagnostic performance of different techniques. 
Based on this approach, I have compared the accuracy between cytology and histology.      
I have also evaluated the agreement rate of cytological reports obtained by two different 
independent reviewers, in order to determine whether the proposed cytological clues 
are repeatable in a clinical setting by differently experienced readers.  
 
9. MATERIAL AND METHODS USED 
Inclusion criteria and tissue samples: the present study included retrospectively dogs 
that suffered from gastrointestinal symptoms such as diarrhea and vomiting and that 
had been endoscopically examined by Dr. Enrico Bottero between October 2007 and 
October 2012. Cases were included only if complete clinical data were available, if cyto-
logical samples were available for reviewing and if a histological diagnosis was availa-
ble for each case. 
Two biopsy samples were obtained from each lesion using endoscopic biopsy forceps 
and then submitted to a cytologic and histologic examination. One of the samples was 
fixed in 10 percent buffered formalin, routinely processed and histopathologically evalu-
ated. All samples were classified into two groups: lymphoma and enteritis groups. Cas-
es of canine enteropathy-type lymphoma diagnosis were confirmed by clinical aspect, 
EOG, endoscopic features, cytology, hystology and follow up. The cytological samples 
were independently and blindly reviewed from two clinical pathologists with different ex-
perience level, respectively, both not specialised in gastroenteric cytology. Histologic 
endoscopic biopsy of small intestine from each dog were evaluated blindly by one 
pathologist, and based on the microscopic appearance of the most severely affected 
section, a diagnosis of IBD, T-cell lymphoma, or B-cell lymphoma was given following 
published criteria. Biopsy samples of ileum and jejunum were available from all dogs. 
No gastric or large intestinal biopsies were examined. 
Cytological samples were prepared by a “squash technique” as follows. 
A small amount of material was placed on a clean glass slide approximately 1⁄2 inch (1 
cm) from the frosted end (Fig. A,B,C). A second clean glass slide was placed over the 
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specimen at right angles. The specimen was gently but firmly compressed between the 
two glass slides and in the same continuous motion the top slide was pulled along the 
surface of the bottom slide, directing the material away from the frosted end (Fig. D,E).  
In this way, a multicellular mass was turned into a thin monolayer ideal for maximal flat-
tening of individual cells and stain penetration, optimizing the specimen for the micro-
scopic examination. A properly prepared glass slide is characterized by a feather-
shaped (oblong) area with a monolayer end referred to as the “sweet spot”.  A common 
mistake is the initial placement of excess sample on the glass slide, resulting in a thick 
preparation that is not possible to adequately examine microscopically. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IMAGE A-E. Solid material preparation. A, The procedure for making a cytologic 
preparation from a tissue sample is illustrated. Specimens for cytologic examination 
were obtained during routine endoscopic examination of the small intestine. B, Tissue 
rolling. Small pieces of tissue that cannot be grasped with a forceps for imprinting can 
be gently placed on a slide using a 25-gauge needle( C). D E. A second clean glass 
slide is placed over the specimen at right angles. The specimen is gently but firmly 
compressed between the two glass slides and in the same continuous motion the top 
slide is pulled along the surface of the bottom slide, directing the material away from the 
frosted end. 
   
Image A                                                      Image B 
   
Image C                                                       Image D 
   Image E 
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Staining the specimen: Romanowsky-type stains were utilized because of their rapidity 
and easiness to use (BOX1). They are a combinations of basic and acidic dyes dis-
solved in methyl alcohol. These polychromatic stains impart the basophilic and eosino-
philic tinctorial properties observed on blood films. 
The stained specimen is examined microscopically using the 10 or 20 mm objective for 
staining quality and uniformity. When a 40 mm objective is to be used, a coverslip is 
usually placed on the specimen. A temporary mount is made by placing a drop of im-
mersion oil on the specimen, followed by a coverslip. A permanent mount is made with 
a commercially available coverslip mounting glue (e.g., EukittR, Calibrated Instruments). 
 
 
BOX 1 Suggested Procedure for Staining Cytologic Sample Using Diff-Quik®Solutions 
 
Fixative: 60 to 120 seconds 
Solution 1: 30 to 60 seconds 
Solution 2: 5 to 60 seconds† 
Rinse under cold tap water: 15 seconds 
 
 
Examine staining adequacy using low power; eosinophilia or basophilia can be en-
hanced by returning to Solution 1 or Solution 2, respectively, followed by a rinse. 
Air-dry and examine   
 
 
 CYTOLOGY 
Description of different cytological features: Cytological smear were evaluated and the 
following aspects were recorded for each sample: 
 
¬small lymphocytes 
¬plasma cells 
¬eosinophils 
¬immature lymphoid cells  
¬membrane alterations of the lymphoid cells  
¬atipical mitoses 
¬presence of lympho glandular bodies 
¬cytomorphologic anomalies in enterocytes  
 
 
In the second part of the study we have blindly re-evaluated the same samples using a 
reduced number of selected cytomorphological features. In particular, three cytological 
features selected as recurrent in the first step of the study were identified independently 
by two readers: 
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¬presence of lymphoid blast cells 
¬fine structural change of the lymphoid blasts’s membrane  
¬presence of lympho-glandular bodies 
 
For each cytologic feature and reader, sensibility and specificity were evaluated. As ref-
erence the final diagnosis drawn by the specialist in gastroenterology who was the only 
aware of all the results of different diagnostic tests (including histopathology), clinical 
features, endoscopic aspect and follow up/response to therapy. In order to cpmpare the 
results obtained by the different readers and the different techniques further evaluation 
were then performed using the test of Cohen’s kappa coefficient for inter-rater agree-
ment. Predictive positive and negative values were also evaluated. 
 
 
 
 
 
 
 
LARGE IMMATURE LYMPHOID CELLS 
Medium-sized or large lymphocytes often compose 50% of the total cells in lymphomas. 
An exception is the presentation of alimentary lymphoma in which reactive lymphocytes 
represent the majority of the cell population. The population is often homogenous when 
cell populations are mixed, including different cell sizes present such as small and large 
lymphocytes, the diagnosis of lymphoma requires additional procedures. The cell size 
based on comparison of the nucleus to the size of an erythrocyte. 
 
• Small: 1-1.5 RBC 
• Medium: 2-2.5 RBC 
• Large: .>3 RBC 
 
 
Immature lymphoid cells, intestine,dog.  Lymphoma T.  (Wright-Giemsa; HP oil) 
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LYMPHOGLANDULAR BODIES 
Lymphoglandular bodies result from the rupture of lymphocytes and appear as small 
platelet-sized basophilic cytoplasmic fragments. Although they may be seen in benign 
lymph node conditions, a higher frequency is expected in lymphoma because of the 
immaturity and fragility of these cells. Lysed nuclei may appear as a lacy, amorphous 
eosinophilic material. 
 
  
 
Lymphoglandular bodies, intestine,dog. Prominent basophilic round structures of 
variable size indicate fragmentation of the cytoplasm. This appearance is often associ-
ated with lymphoma but may be found in other conditions having fragile cells. (Wright-
Giemsa; HP oil.) 
 
NUCLEAR  MEMBRANE 
Morphologic appearance of the neoplastic cells has been used along with immunophe-
notype to further classify the lymphomas for prognostic value (Ponce et al.,2004). 
Nuclei are generally described according to different aspects: 
 
• Round: circular with no indentations 
• Irregularly round: few indentations or convolutions 
• Convoluted: several deep indentations 
• Clefted: single deep indentation 
• Central vs. eccentric placement 
 
 
Irregual morphologic appearance of balt membrane, intestine,dog. Lymphoma T.  
(Wright-Giemsa; HP oil) 
 
68 
 
HYSTOPATHOLOGY 
 
Histopatologic evalutation: biopsy samples of ileum and jejunum were available from all 
dogs. No gastric or large intestine biopsies were examined. The endoscopic tissues 
consisted of mucosa and submucosa. For all cases, sufficient formalin-fixed, paraffin-
embedded samples were available for further testing. Serial sections from paraffin tis-
sue blocks from each of the 20 dogs were cut for routine HE staining. 
The canine IBD activity index (CIBDAI) was used for evaluation of the severity of illness 
(box2) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Box2: Histological Scoring System used to evaluate the degree of intestinal inflammation 
 
Intestinal Histologic Scoring System   
Feature Scored Score Description 
Inflammation 
Severity 
0 None 
1 Mild 
2 Moderate 
3 Severe 
Inflammation 
Extent 
0 None 
1 Mucosa 
2 Mucosa and 
Submucosa 
3 Transmural 
Crypt 
Damage 
0 None 
1 1/3 of crypt damaged 
2 2/3 of crypt damaged 
3 Crypts lost, surface 
epithelium present 
4 Crypts and surface 
epithelium lost 
Percent 
involvement 
0 0% 
1 1–25% 
2 26–50% 
3 51–75% 
4 76–100% 
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IMMUNOHISTOCHEMISTRY 
 
Serial sections were deparaffinized and rehydrated for routine immunohistochemistry 
(IHC) to detect expression of CD3 (1:20 dilution; P. Moore, UC Davis, Davis, CA) in T 
cells and CD79a (1:125 dilution; Clone HM57, Dako, Carpinteria, CA) in B cells. Serial 
sections from paraffin tissue blocks from 14 dogs were cut for immunophenotyping 
analysis (Fig 1-2). 
 
       
Figure 1                                                                                 Figure 2 
 
Fig 1-2 Immunohistochemical staining of biopsy specimen taken from dog N°17. 
(1) Few neoplastic lymphocytes are stained by B cell marker, CD79a. (2) Many neo-
plastic lymphocytes are positively stained by T cell marker, CD3.
10. STATISTICAL ANALYSIS 
 
Diagnostic performances of the different  techniques and the different observers were 
calculated. Since, to our knowledge, no universally accepted gold standard has been 
defined to differentiate IBD from intestinal lymphoma using endoscopic biopsies we de-
cided to blindly compare all the cytological and histological results with the final diagno-
sis drawn by the specialist in gastroenterology according to all the results of clinical ex-
amination, endoscopy, extemporaneous cytology, histopathology and confirmed with 
follow-up and response to treatment. All the techniques were separately compared with 
this clinical diagnosis in order to define their performance and reproducibility and to po-
tentially identify some features which could be used discriminate IBD from lymphoma. 
Cohen's kappa coefficient is a statistical measure of inter-rater agreement or inter-
annotator agreement for qualitative (categorical) items. It is generally thought to be a 
more robust measure than simple percent agreement calculation since κ takes into ac-
count the agreement occurring by chance. It measures the agreement between two 
raters who each classify N items into C mutually exclusive categories. The first mention 
of a kappa-like statistic is attributed to Galton (1892), see Smeeton (1985).  
The equation for κ is:  
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where Pr (a) is the relative observed agreement among raters, and Pr (e) is the hy-
pothetical probability of chance agreement, using the observed data to calculate the 
probabilities of each observer randomly saying each category. If the raters are in 
complete agreement then κ = 1. If there is no agreement among the raters other 
than what would be expected by chance (as defined by Pr(e)), κ = 0. 
 
 
 
 
 
 
 
 
 
 
The positive predictive value, or precision rate is the proportion of positive test results 
that are true positives. It is a critical measure for the performance of a diagnostic meth-
od, as it reflects the probability that a positive test reflects the underlying condition being 
tested for. Its value does however depend on the prevalence of the outcome of interest, 
which may be unknown for a particular target population. 
 Cohen’s Kappa Index 
  
 
      
  
Test A 
  
  
Yes No 
  
Test B    
Yes   0  
 No    0  
 
  
0  0  0  
 
      Accumulative concordance
 Cohen’s Kappa 
    
      interpretation: 
 
 values < 0 as indicating no agreement and  
        0–0.20 as slight 
        0.21–0.40 as fair 
        0.41–0.60 as moderate 
        0.61–0.80 as substantial 
        0.81–1 as almost perfect agreement. 
    
     
     
     
  0.41-0.60   moderata  
  0.61-0.80   buona  
  
0.81-1.00 
  eccel-
lente 
 
  
  
  
   
 The Positive Predictive Value is defined as: 
 
 
 
The negative predictive value (NPV) is a summary statistic used to describe the perfor-
mance of a diagnostic testing procedure. It is defined as the proportion of subjects with 
a negative test result who are correctly diagnosed. A high NPV for a given test means 
that when the test yields a negative result, it is most likely correct in its assessment. In 
the familiar context of medical testing, a high NPV means that the test only rarely mis-
classifies a sick subject as being healthy. Note that this says nothing about the tenden-
cy of the test to mistakenly classify a healthy subject as being sick. 
The Negative Predictive Value is defined as: 
 
 
The following diagram illustrates the relation positive predictive value,  negative predic-
tive value, sensitivity, and specificity. 
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Condition 
(as determined by "Gold 
standard") 
Condition 
Positive 
Condition 
Negative 
Test 
Outcome 
Test 
Outcome 
Positive 
True Positive 
False Positive 
(Type I error) 
Positive predictive  
value = 
Σ True Positive 
Σ Test Outcome Positive 
Test 
Outcome 
Negative 
False Negative 
(Type II error) 
True Negative 
Negative predictive val-
ue = 
Σ True Negative 
Σ Test Outcome Negative 
 
Sensitivity = 
Σ True Positive 
Σ Condition Positive 
Specificity = 
Σ True Negative 
Σ Condition Negative 
 
11. RESULTS 
 
Of the 20 dogs with intestinal lymphoma, the most common breeds were Boxers (3), 
Beagles (3) and mongrels (2). Mean age in the lymphoma group was 8,2 years. The 
clinical presentation of dogs with intestinal lymphoma in this study was similar to those 
of dogs in previous reports, ranging from nonspecific symptoms such as anorexia and 
lethargy to more specific gastrointestinal symptoms such as vomiting and hemorrhagic 
diarrhea. In particular, the frequencies of clinical findings attributed to the intestinal tu-
mor were: vomiting 61%, weight loss 100% (fig3) and diarrhea 100% (fig 4), of which 
72% was considered severe. Recent history revealed a progressive worsening of clini-
cal signs, not responding to symptomatic therapy or relapsing rapidly after an initial im-
provement. The mean time between the onset of clinical signs and the clinical presenta-
tion was 5,26 weeks, which is much shorter that the same time interval of dogs with 
IBD: in our study, this time interval was longer than 3 months. The CBC of dogs with in-
testinal lymphoma showed mild to marked anemia in 88% of cases, leukocytosis with 
left shift in 25% of cases. Hypoalbuminemia was a common abnormal biochemical find-
ing: 72% of the dogs with intestinal lymphoma had a low serum albumin concentration, 
with most of them (84%) having less than 2 g/dL (reference interval, 3.1–4.1 g/dL).  
All dogs with intestinal lymphoma were normocalcemic, when adjusted for concurrent 
hypoalbubinemia; 30% of the dogs had hypocolesterolemia and 70% had hypocobala-
minemia.  
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Abdominal radiography showed non-specific findings whereas abdominal ultrasonogra-
phy showed an enteritis-like aspect (70%) with an increased thickness of the intestinal 
wall and mesenteric lymphadenopathy (45%) (fig5). In 20% of patients, the ultraso-
nographic exam was normal.  
The endoscopic examination showed a clobbed paving aspect of the mucosa in 50% of 
the patients (fig6). 
Fig.3                                                                                      Fig4 
     
    
Fig5                                                                                Fig6 
11.1 Cytological Results 
The present study included 71 dogs that suffered from gastrointestinal symptoms: 20 
cases of enteropathy-type lymphoma and 52 cases of inflammatory enteropathy. 
The cytological samples were independently revued and subjected to a blind study from 
two clinical pathologists with different experience, although not expert in gastroenterolo-
gy. The casistic included 20 cases of enteropathy-type lymphoma and 52 cases of in-
flammatory enteropathy. Cytologic smears were evaluated, drawing a temptative diag-
nosis according to the cytomorphological aspect. 
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Table 1: Review from 2 pathologyst of 20 cases of enteropathy-type lymphoma  
PATIENT A B FINAL DIAGNOSIS 
Patient 1 ENTERITIS ENTERITIS LYMPHOMA 
Patient 2 ENTERITIS LYMPHOMA LYMPHOMA                 
Patient 3 LYMPHOMA ENTERITIS LYMPHOMA 
Patient 4 ENTERITIS LYMPHOMA LYMPHOMA 
Patient 5 ENTERITIS LYMPHOMA LYMPHOMA                        
Patient 6 LYMPHOMA LYMPHOMA LYMPHOMA                                  
Patient 7 LYMPHOMA LYMPHOMA LYMPHOMA                                    
Patient 8 LYMPHOMA LYMPHOMA LYMPHOMA                                
Patient 9 ENTERITIS ENTERITIS LYMPHOMA 
Patient 10 LYMPHOMA LYMPHOMA LYMPHOMA 
Patient 11 ENTERITIS ENTERITIS LYMPHOMA                
Patient 12 ENTERITIS LYMPHOMA LYMPHOMA                             
Patient 13 ENTERITIS LYMPHOMA LYMPHOMA 
Patient 14 ENTERITIS ENTERITIS LYMPOMA 
Patient 15 LYMPHOMA LYMPHOMA LYMPHOMA 
Patient 16 LYMPHOMA LYMPHOMA LYMPHOMA 
Patient 17 LYMPHOMA LYMPHOMA LYMPHOMA 
Patient 18 ENTERITIS ENTERITIS LYMPHOMA 
Patient 19 LYMPHOMA LYMPHOMA LYMPHOMA 
Patient 20 LYMPHOMA ENTERITIS LYMPHOMA 
 
 During the first review the observer A and the observer B showed a sensitivity of 50 
percent and 65 percent  respectively. For both of them the specificity was 100 percent 
(box1). The statistics included 20 cases of enteropathy-type lymphoma and 52 cases of 
inflammatory enteropathy This means that no dogs with enteritis were identified as hav-
ing lymphoma. 
(box1) 
Sens.= VP/VP+FN 
Spec.= VN/FP+VN 
A (expert):  
     Se= 10/10+10= 50% 
     Sp= 52/0+52= 100% 
B :   Se=13/13+7=65% 
     Sp= 52/0+52= 100% 
 
All the cytomorphological features identified were reviewed in order to define the most 
relevant in lymphoma samples. According to the results of this first phase three main 
features were identified as mainly associated to lymphoma.Thus, in the second part of 
the study we have blindly re-evaluated the same samples using an interpretative al-
gorythm based on the following selected cytomorphological criteria: 1) presence of lym-
phoid blast cells, 2) membrane alterations of the lymphoiblasts, 3) presence of lympho-
glandular bodies (results are expressed in Table 2) 
  
     
  
Test A 
 
  
+ - 
 
Test B    
+ 10  3  13  
-  0  59  59  
  
10 62  72  
     K Cohen 
  
0,845 
     
 
 
  
  
  
   
    
     
    
    
     
  
 EXCELLENT 
 CONCORDANCE 
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Table 2: 2° review from 2 pathologyst of 20 cases of enteropathy-type lymphoma 
PATIENT A  B FINAL DIAGNOSIS 
Patient 1 ENTERITIS ENTERITIS LYMPHOMA 
Patient 2 LYMPHOMA LYMPHOMA LYMPHOMA                 
Patient 3 LYMPHOMA ENTERITIS LYMPHOMA 
Patient 4 LYMPHOMA LYMPHOMA LYMPHOMA 
Patient 5 LYMPHOMA LYMPHOMA LYMPHOMA                        
Patient 6 LYMPHOMA LYMPHOMA LYMPHOMA                                  
Patient 7 LYMPHOMA LYMPHOMA LYMPHOMA                                    
Patient 8 LYMPHOMA LYMPHOMA LYMPHOMA                                
Patient 9 LYMPHOMA LYMPHOMA LYMPHOMA 
Patient 10 LYMPHOMA LYMPHOMA LYMPHOMA 
Patient 11 ENTERITIS ENTERITIS LYMPHOMA                
Patient 12 LYMPHOMA LYMPHOMA LYMPHOMA                             
Patient 13 LYMPHOMA LYMPHOMA LYMPHOMA 
Patient 14 ENTERITIS LYMPHOMA LYMPOMA 
Patient 15 LYMPHOMA LYMPHOMA LYMPHOMA 
Patient 16 LYMPHOMA LYMPHOMA LYMPHOMA 
Patient 17 LYMPHOMA LYMPHOMA LYMPHOMA 
Patient 18 ENTERITIS ENTERITIS LYMPHOMA 
Patient 19 LYMPHOMA LYMPHOMA LYMPHOMA 
Patient 20 LYMPHOMA ENTERITIS LYMPHOMA 
 
 During the second review the observer A showed a sensitivity of 85 percent, while the 
observer B of 80 percent. For both the specificity was 100% (box2). The statistics in-
cluded 20 cases of enteropathy-type lymphoma and 52 cases of inflammatory enteropa-
thy. This means that no dogs with enteritis were identified as having lymphoma. 
(box2) 
Sens.= VP/VP+FN 
Spec.= VN/FP+VN 
 A: 
    Se= 17/17+3= 85% 
     Sp= 52/0+52= 100% 
 B:   Se= 16/16+4= 80% 
     Sp= 52/0+52= 100% 
 
 
If we consider each cytologic feature independently the results in patients with lympho-
ma were as follows: 
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For the observer A:  
immature lymphoid cells analysis  
Sens.= VP/VP+FN 
Spec.= VN/FP+VN 
    Se= 18/18+2= 90% 
     Sp= 50/2+50= 96% 
membrane alterations of the lymphoid blasts  
Sens.= VP/VP+FN 
Spec.= VN/FP+VN 
    Se= 13/13+7= 65% 
     Sp= 45/7+45= 87% 
lympho-glandular bodies  
Sens.= VP/VP+FN 
Spec.= VN/FP+VN 
    Se= 12/12+8= 60% 
     Sp= 44/8+44= 85% 
 
 
 
 
Table 3: scoring of observer A in 20 cases of lymphoma, using the 3 main cyto-
logical diagnostic features.  observer A 
 
PATIENT diagnosis blast membrane lg bodies 
Patient 1 ENTERITIS NO NO NO 
Patient 2 LYMPHOMA YES NO NO 
Patient 3 LYMPHOMA YES YES NO 
Patient 4 LYMPHOMA YES NO YES 
Patient 5 LYMPHOMA YES YES YES 
Patient 6 LYMPHOMA YES YES YES 
Patient 7 LYMPHOMA YES YES NO 
Patient 8 LYMPHOMA YES YES YES 
Patient 9 LYMPHOMA YES NO YES 
Patient 10 LYMPHOMA YES YES NO 
Patient 11 ENTERITIS NO NO NO 
Patient 12 LYMPHOMA YES YES YES 
Patient 13 LYMPHOMA YES YES NO 
Patient 14 ENTERITIS YES YES YES 
Patient 15 LYMPHOMA YES YES NO 
Patient 16 LYMPHOMA YES YES YES 
Patient 17 LYMPHOMA YES YES YES 
Patient 18 ENTERITIS YES NO YES 
Patient 19 LYMPHOMA YES YES YES 
Patient 20 LYMPHOMA YES NO YES 
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For the observer A, the positive and negative predictive values of each diagnostic crite-
rion both in IBD and lymphoma patients were as follows: 
Blast Cells
FN
VP
 
Membrane alteration
FN
VP
 
LGB
FN
VP
 
 
VPP= 82% 
VPN=96% 
VPP= 87% 
VPN=85% 
VPP= 92% 
VPN=86% 
For observer B (expert) the results, in patients with IBD and lymphoma, were as follows: 
immature lymphoid cells analysis  
Sens.= VP/VP+FN 
Spec.= VN/FP+VN 
    Se= 16/16+4= 80% 
     Sp= 50/4+50= 93% 
membrane alterations of the lymphoid blasts  
Sens.= VP/VP+FN 
Spec.= VN/FP+VN 
    Se= 15/15+5= 75% 
     Sp= 47/5+47= 90% 
lympho-glandular bodies  
Sens.= VP/VP+FN 
Spec.= VN/FP+VN 
    Se= 13/13+7= 65% 
     Sp= 45/7+45= 87% 
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Table 4: scoring of observer A in 20 cases of lymphoma, using the 3 main cyto-
logical diagnostic features.  observer B 
 
PATIENT diagnosis blast membrane Clg 
Patient 1 ENTERITIS NO NO NO 
Patient 2 LYMPHOMA YES YES NO 
Patient 3 ENTERITIS YES YES NO 
Patient 4 LYMPHOMA YES NO YES 
Patient 5 LYMPHOMA YES YES YES 
Patient 6 LYMPHOMA NO YES YES 
Patient 7 LYMPHOMA YES YES NO 
Patient 8 LYMPHOMA YES YES YES 
Patient 9 LYMPHOMA YES NO YES 
Patient 10 LYMPHOMA YES YES NO 
Patient 11 ENTERITIS NO NO NO 
Patient 12 LYMPHOMA YES YES YES 
Patient 13 LYMPHOMA YES YES NO 
Patient 14 LYMPHOMA YES YES YES 
Patient 15 LYMPHOMA YES YES YES 
Patient 16 LYMPHOMA YES YES YES 
Patient 17 LYMPHOMA YES YES YES 
Patient 18 ENTERITIS NO YES YES 
Patient 19 LYMPHOMA YES YES YES 
Patient 20 ENTERITIS NO NO YES 
 
 For observer B, the positive and negative predictive values of each diagnostic criterion 
both in IBD and lymphoma patients were as follows: 
 
 
 
LGB
FN
VP
 
VPP= 100% 
VPN=93% 
VPP= 100% 
VPN=91% 
VPP= 100% 
VPN=88% 
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The next tables show the disaggregate concordance index of three morphological crite-
ria between observers A and B:  
                    
Blast cells: Cohen’s Kappa 
  
 
      
  
Test A 
  
  
+ - 
  
Test B 
+ 16 0 16 
 - 2 2 4 
 
  
18 2 20 
 
      
     Cohen’ K=0.615 GOOD 
  
Membrane alteration : Cohen’s Kappa 
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11.2  Histological results 
Fourteen histological samples of dogs with lymphoma were available for reviewing by a 
reference pathologist (table 5). HE-stained sections were blindly analyzed by a 
pathologist  in parallel with immunohistochemistry preparations for CD3e and CD79a. I 
evaluate the diagnostic accuracy of gold standard and histologic results for the diagno-
sis of lymphoma (79%). 
Table 5: Patient with lymphoma avaiable for histological rview 
PATIENT Gold Standard Histological Diagnosis 
Patient1 LYMPHOMA LYMPHOMA                 
Patient2 LYMPHOMA                 LYMPHOMA 
Patient3 LYMPHOMA LYMPHOMA                      
Patient5 LYMPHOMA                        LYMPHOMA                               
Patient6 LYMPHOMA                                  ENTERITIS                                   
Patient7 LYMPHOMA                                    LYMPHOMA                                
Patient8 LYMPHOMA                                LYMPHOMA                
Patient11 LYMPHOMA                LYMPHOMA                         
Patient12 LYMPHOMA                             LYMPHOMA 
Patient13 LYMPHOMA LYMPHOMA 
Patient14 LYMPOMA LYMPHOMA 
Patient16  LYMPHOMA LYMPHOMA 
Patient17 LYMPHOMA ENTERITIS 
Patient18 LYMPHOMA ENTERITIS 
 
 
Accuracy = VP + VN/VP + VN + FN + FP = 79% 
Based on histologic features and immunohistochemistry for CD3 and CD79a, a diagno-
sis of IBD, T-cell lymphoma, or B-cell lymphoma was made using published criteria (ta-
ble 6) and revealed that the majority of neoplastic lymphocytes were positive for CD3. 
In our study, in 6 out of 8 dogs with alimentary lymphoma an immunophenotypic analy-
sis confirmed a T-cell origin of the disease. 
Table 6 
PATIENT Histological Diagnosis HIC 
Patient1 LYMPHOMA                 LYMPHOMA(T) 
Patient2 LYMPHOMA LYMPHOMA(T) 
Patient3 LYMPHOMA                   ENTERITIS 
Patient5 LYMPHOMA                               LYMPHOMA(T) 
Patient6 ENTERITIS                                   ENTERITIS 
Patient7 LYMPHOMA                                LYMPHOMA(B) 
Patient8 LYMPHOMA                LYMPHOMA(B) 
Patient11 LYMPHOMA                         LYMPHOMA(T) 
Patient12 LYMPHOMA LYMPHOMA(T) 
Patient13 LYMPHOMA ENTERITIS 
Patient14 LYMPHOMA LYMPHOMA(T) 
Patient17 ENTERITIS ENTERITIS 
Patient18 ENTERITIS ENTERITIS 
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The agreement index calculated with Cohen’s kappa coefficient, between histology and 
hic,  was 0.649 (i.e., substantial). 
 
 
 
Index «Kappa» ‘s di Cohen 
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12. DISCUSSION 
 
 
Among the intestinal tumours of hematopoietic cell origin, lymphoma is the most com-
mon in dogs (Guillform WG and Strombeck DR, 1996) with primary intestinal lymphoma 
being less common than the multicentric form (Head KW et al, 2002). 
Alimentary lymphoma, common in cats, usually accounts for 7% of all canine lympho-
mas and 5-7% of all gastrointestinal neoplasms (Theilen, G. H. and Madewell, B. R. 
1979). A recent report has indicated that the majority of canine intestinal lymphoma is of 
T-cell origin. It has been divided in two types based on morphological characteristics of 
the tumour cells: small to moderate-sized lymphoma showing epiteliotropic behaviour, 
and moderate to large sized lymphoma with or without epitheliotropism (Coyle KA et al, 
1996; Steimber H et al, 1995). 
 The former type has been classify as intestinal T-cell lymphoma according to the World 
Health Organization (WHO) classification system (Valli VE et al, 2002). MALT lympho-
ma, a small, usually of B-cell origin tumor, leads to the formation of submucosal mass,  
wehereas the epitheliotropic T-cell lymphoma (also known as intestinal T-cell lympho-
ma) is usually multifocal and/or diffuse throughout the submucosa and the lamina pro-
pria of the intestine, especially in the small intestine, with frequent superficial ulceration 
and occasional transmural infiltration of the serosa (Willard, M. D et al, 2002). Lympho-
cytic- plasmacytic inflammation adjacent to or distant from the primary tumour can oc-
cur, and distinguishing between alimentary lymphoma and enteritis, especially lympho-
cytic- plasmacytic enteritis (LPE), can be difficult (Couto et al, 1989; Valli D.M. and 
Young, K.M. 2007). Generally, the prognosis of the alimentary lymphoma is poor as 
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compared to that of the multicentric form, regardless of treatment (Rassnick, K. M. et al,  
2009).  
Currently, no clear consensus exists regarding sex predilection for canine lymphoma. In 
some studies, the percentage of males affected with gastrointestinal lymphoma was 
higher than that of females, while no difference was found in other studies (Keller ET et 
al, 1993;  Kiupel M et al, 1999).  In our study, no significant sex difference was identified 
although this finding should be considered with caution because of the low number of 
cases examined. 
In light of the clinical and symptomatic overlapping between IBD and enteropathy-type 
lymphoma, patients are often submitted to endoscopic examination for a definitive diag-
nosis. During the first stage of the disease, the enteropathy-type lymphoma is principally 
localized in the mucosa and the neoplastic infiltration is enough to cause an abnormal 
digestive function with non-specific gastro-intestinal signs. The endoscopic examination 
of the small bowel in the lymphoma group showed an aspect referred by gastroenterol-
ogists as cobblestone appearance of the intestinal mucosa (50 %): the intestinal muco-
sa looked friable, edematous, irregularly thickened and with a cobblestone appearance. 
In dogs with this endoscopic aspect, the cytological examination alone has shown in our 
study a good diagnostic accuracy in the differential diagnosis between lymphoma and 
IBD. 
In our study, the cytological samples were independently and blindly reviewed by two 
clinical pathologists with different level of experience, although both of them had no 
specific expertise in gastroenteric cytology. During the first review, the experienced 
pathologist showed a lower sensitivity than the inexperienced one, whereas the specific-
ity was 100 percent for both. These results might be explained by the tendency of more 
experienced pathologists to be more conservative in their judgement in order to avoid 
false positive results. The agreement index calculated using the Cohen's kappa coeffi-
cient was 0.5 and it can be defined as a "mild" concordance.  
In the second part of the cytology study we have blindly re-evaluated the same samples 
using an interpretative algorythm based on a reduced number of some selected cyto-
morphological clues defined by the expert gastroenterologist. These criteria were: 1) 
presence of lymphoid blast cells; 2) membrane alterations of the lymphoid blasts; 3) 
presence of lympho-glandular bodies. During the second review the observer A (experi-
enced cytologist) showed a higher sensitivity compared with the observer B (inexperi-
enced cytologist). For both cytologists the specificity was again 100 percent. The 
agreement index calculated with Cohen’s kappa coefficient was 0.986 (i.e., "excellent" 
correlation).  
The most sensitive and specific single cytomorphological criterion in differentiating en-
teric lymphoma from IBD was the presence of immature lymphoid cells (A: Se= 90%; 
Sp= 96% B: Se= 80%; Sp= 93%), although combing all criteria provides the best accu-
racy. The concordance index calculated with Cohen’s kappa coefficient was good for all 
three criteria. In this study, the group of dogs with intestinal lymphoma had a very short 
median survival time (25 days) and the response to various therapeutic regimens was 
poor. A possible explanation for the poor response to treatment could be related to the 
immunophenotype of the lymphomas included in our study. Most cases of canine gas-
trointestinal lymphoma have been assumed to be of B-cell origin, likely based on the 
fact that almost all human, non-Hodgkin’s lymphomas are of B-cell origin ( Aster J et al, 
96 
 
1999; Ozaki K.et al, 2006). However, it is now known that canine gastrointestinal lym-
phoma is more commonly of T-cell origin (Miura T et al, 2004;  Carter RF et al,1986). 
 In our study, when immunophenotyping was performed, T-cell lymphoma was diag-
nosed in 71 percent of cases and B-cell lymphoma in 29 percent of cases. Because T-
cell lymphomas may have a more aggressive biological behaviour and are less respon-
sive to chemotherapeutic treatment, dogs with a gastrointestinal lymphoma may be less 
responsive to chemotherapy (Cartel et al, 1986). In the present study, however lym-
phoma subtype seemed to have no influence on survival time, although this conclusion 
must be interpreted with caution due to the low number of cases examined. 
In conclusion, cytological examination of squash-prep samples could be very useful in 
addressing infiltrating enteropahy, using the proposed diagnostic criteria. The most out-
standing result of our study, was the higher diagnostic accuracy of squash-prep cytolo-
gy compared with histology. 
Histopathology and immunohistochemistry are generally considered useful in the differ-
ential diagnosis between IBD and lymphoma. 
Seventy-ﬁve percent of the alimentary lymphomas in this study stained positively for the 
CD3 marker, indicating a T-cell origin for these tumors in dogs, whereas only 25 percent 
stained positively for the B-cell marker. This is opposite to the pattern seen in humans, 
wherein a B-cell is the origin of nearly all non-Hodgkin’s lymphomas. Several studies on 
humans have found the incidence of B-cell lymphoma to be from 50 up to 100 percent 
when compared with T-cell lymphomas (Hansen PB et al 1998; Parodi AL et al, 1988; 
Teske E et al, 1994; Vinzio S et al, 1998). Primary gastrointestinal T-cell lymphomas are 
so rare in humans that several studies either do not address T versus B-cell as a prog-
nostic indicator, even though tumors were identiﬁed by the immunotype (Hansen PB et 
al 1998; Parodi AL et al, 1988), or  all the tumors in the study were of B-cell origin 
(Whooley BPet al,1998). 
 In our findings however, although the evaluation of histopathologic results is not within 
the aims of this study, the diagnostic performances of histopathology were not better 
than those of cytology alone. In our view, this stresses the possible role of cytology for 
diagnosing intestinal lymphoma and suggests that a wider panel of tests including cytol-
ogy, histology, immunophenotyping and possibly molecular biology techniques (PCR for 
antigen receptor rearrangement or PARR) is mandatory to address the problems of a 
differential diagnosis. 
In our view, only an accurate evaluation of both clinical, imaging and laboratory results 
by a specialist in gastroenterology may bring to a final diagnosis and appropriate treat-
ment and prognosis.  
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